{
    "items": "209",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "Is Kenvue Stock Too Pricey to Buy?",
            "url": "https://www.fool.com/investing/2023/09/30/is-kenvue-stock-too-pricey-to-buy/",
            "time_published": "20230930T132200",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "Its valuation depends on its brands being highly valuable indefinitely.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.990786"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.271692,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.20698",
                    "ticker_sentiment_score": "0.202704",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.069697",
                    "ticker_sentiment_score": "0.087708",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Magnificent Dividend Stocks to Buy in October",
            "url": "https://www.fool.com/investing/2023/09/30/3-magnificent-dividend-stocks-to-buy-in-october/",
            "time_published": "20230930T105500",
            "authors": [
                "Keith Speights",
                "David Jagielski",
                "and Prosper Junior Bakiny"
            ],
            "summary": "These stocks come with great dividends and more.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                }
            ],
            "overall_sentiment_score": 0.244586,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.350564",
                    "ticker_sentiment_score": "0.204761",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.179788",
                    "ticker_sentiment_score": "0.03029",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.266828",
                    "ticker_sentiment_score": "0.205411",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine",
            "url": "https://www.fool.com/investing/2023/09/30/heres-why-you-should-consider-moderna-stock-and-no/",
            "time_published": "20230930T093000",
            "authors": [
                "Jeff Santoro"
            ],
            "summary": "The COVID-19 vaccine put Moderna on the map, but its pipeline is going to be what keeps it there.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999612"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.064365,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.673371",
                    "ticker_sentiment_score": "0.060061",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.06515",
                    "ticker_sentiment_score": "0.114691",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.06515",
                    "ticker_sentiment_score": "0.114691",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Federal judge declines to block Medicare price negotiations",
            "url": "https://www.cnbc.com/2023/09/29/medicare-price-negotiations-federal-judge-denies-injunction-request.html",
            "time_published": "20230929T213958",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "Judge Michael Newman of the Southern District of Ohio issued a ruling denying a preliminary injunction sought by the Chamber of Commerce.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106330644-1578667127386rts2xt0x.jpg?v=1696023598&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": -0.024126,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.057907",
                    "ticker_sentiment_score": "-0.117981",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.057907",
                    "ticker_sentiment_score": "-0.117981",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.057907",
                    "ticker_sentiment_score": "-0.117981",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057907",
                    "ticker_sentiment_score": "-0.102975",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Announcing the 2023 Most Powerful Latina Summit at L'attitude: Elevating Latina Leaders and Charting the Future of Global Economy",
            "url": "https://www.prnewswire.com/news-releases/announcing-the-2023-most-powerful-latina-summit-at-lattitude-elevating-latina-leaders-and-charting-the-future-of-global-economy-301942564.html",
            "time_published": "20230929T150000",
            "authors": [
                "Association of Latino Professionals For America"
            ],
            "summary": "Announcing the 2023 Most Powerful Latina Summit at L'attitude: Elevating Latina Leaders and Charting the Future of ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2016784/ALPFA_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.340634,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ARES",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.096311",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GT",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.096311",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.197109",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.096311",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Third Quarter 2023: CINDE Announces 28 New Multinationals Confirm Arrival to Costa Rica",
            "url": "https://www.prnewswire.com/news-releases/third-quarter-2023-cinde-announces-28-new-multinationals-confirm-arrival-to-costa-rica-301943060.html",
            "time_published": "20230929T143800",
            "authors": [
                "CINDE"
            ],
            "summary": "• The companies that have chosen to set up new operations in this country are from , , , , and . • Nine of the companies will be setting up outside the greater metropolitan area, some of the selected regions being Orotina, Turrialba, Puntarenas, Grecia, Puerto Viejo de Sarapiquí, Bagaces, and ...",
            "banner_image": "https://mma.prnewswire.com/media/2235040/CINDE2.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.25099,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HTHIF",
                    "relevance_score": "0.071145",
                    "ticker_sentiment_score": "0.18229",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ZUO",
                    "relevance_score": "0.071145",
                    "ticker_sentiment_score": "0.18229",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TRU",
                    "relevance_score": "0.071145",
                    "ticker_sentiment_score": "0.18229",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.071145",
                    "ticker_sentiment_score": "0.18229",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment",
            "url": "https://www.marketwatch.com/story/as-merck-astrazeneca-and-other-drugmakers-sign-on-medicare-price-negotiations-face-critical-moment-9d85879f",
            "time_published": "20230929T142000",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.",
            "banner_image": "https://images.mktw.net/im-860220/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.004787,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.100099",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.100099",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.149656",
                    "ticker_sentiment_score": "0.138204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.100099",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.100099",
                    "ticker_sentiment_score": "-0.006512",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.100099",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Artwork Management Software Market worth $1.12 Billion by 2030 - Exclusive Report by The Insight Partners",
            "url": "https://www.benzinga.com/pressreleases/23/09/g35002288/artwork-management-software-market-worth-1-12-billion-by-2030-exclusive-report-by-the-insight-part",
            "time_published": "20230929T132658",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Pune, India., Sept. 29, 2023 ( GLOBE NEWSWIRE ) -- According to a new report on \"Artwork Management Software Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Deployment ( Cloud and On-Premise ) , Application ( Life ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.309394,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.031822",
                    "ticker_sentiment_score": "0.171305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.031822",
                    "ticker_sentiment_score": "0.171305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.031822",
                    "ticker_sentiment_score": "0.171305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "A Bull Market Is Coming: 3 Top Dividend Stocks to Buy Now",
            "url": "https://www.fool.com/investing/2023/09/29/bull-market-top-dividend-stocks-to-buy-now/",
            "time_published": "20230929T092300",
            "authors": [
                "Joe Tenebruso"
            ],
            "summary": "These steadfast investments can help you earn more passive income.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.379392,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ENB",
                    "relevance_score": "0.281584",
                    "ticker_sentiment_score": "0.413316",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.334762",
                    "ticker_sentiment_score": "0.290346",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CRBO",
                    "relevance_score": "0.05749",
                    "ticker_sentiment_score": "0.275026",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ARCC",
                    "relevance_score": "0.334762",
                    "ticker_sentiment_score": "0.237497",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05749",
                    "ticker_sentiment_score": "0.144983",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders",
            "url": "https://www.fool.com/investing/2023/09/29/7-dividend-stocks-pay-98-billion-year-shareholders/",
            "time_published": "20230929T092100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "Seven brand-name, time-tested businesses are doling out between $11.2 billion and $22.3 billion to their shareholders each year.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F748759%2Fgetting-paid-dividends-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999186"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.226857,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.119235",
                    "ticker_sentiment_score": "0.07697",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.119235",
                    "ticker_sentiment_score": "0.118616",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.089573",
                    "ticker_sentiment_score": "0.187993",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.119235",
                    "ticker_sentiment_score": "0.04129",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.119235",
                    "ticker_sentiment_score": "0.056052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.089573",
                    "ticker_sentiment_score": "0.085197",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.148731",
                    "ticker_sentiment_score": "0.21756",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/unitaid-urges-johnson-johnson-improve-access-tb-drug-bedaquiline-2023-09-29/",
            "time_published": "20230929T084400",
            "authors": [
                "Reuters"
            ],
            "summary": "Unitaid urges Johnson & Johnson to improve access to TB drug ...",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/D6QKGYC4WRL5RJYHAAXCEDUJM4.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.057355,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.334008",
                    "ticker_sentiment_score": "-0.07906",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Virtualware's VIROO capabilities shown at NATO Exercise",
            "url": "https://www.globenewswire.com/news-release/2023/09/29/2751745/0/en/Virtualware-s-VIROO-capabilities-shown-at-NATO-Exercise.html",
            "time_published": "20230929T053900",
            "authors": [
                "VIRTUALWARE 2007 SA"
            ],
            "summary": "Bilbao, Spain, September 29.- Virtualware ( EPA: MLVIR ) , the European leader in the virtual reality industry, has participated at the NATO Air Operation exercise focused on chemical, biological, radiological, and nuclear ( CBRN ) Def interoperability to present the VR training project for the ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/13948b91-ce96-426f-b8a7-b1586665fb52",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.09457,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HTHIF",
                    "relevance_score": "0.045396",
                    "ticker_sentiment_score": "0.113299",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBDSF",
                    "relevance_score": "0.045396",
                    "ticker_sentiment_score": "0.113299",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AOMFF",
                    "relevance_score": "0.045396",
                    "ticker_sentiment_score": "0.113299",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.045396",
                    "ticker_sentiment_score": "0.113299",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.045396",
                    "ticker_sentiment_score": "0.113299",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Office Real Estate Depression",
            "url": "https://www.fool.com/investing/2023/09/28/the-office-real-estate-depression/",
            "time_published": "20230928T234900",
            "authors": [
                "Motley Fool Staff"
            ],
            "summary": "We've also got a look at two stocks worth watching and a discussion about the AI future.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.996718"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.152433,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GIS",
                    "relevance_score": "0.012037",
                    "ticker_sentiment_score": "0.061258",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.006019",
                    "ticker_sentiment_score": "0.05998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.006019",
                    "ticker_sentiment_score": "0.005772",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FL",
                    "relevance_score": "0.006019",
                    "ticker_sentiment_score": "0.099914",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.006019",
                    "ticker_sentiment_score": "0.076661",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FRFHF",
                    "relevance_score": "0.018055",
                    "ticker_sentiment_score": "0.107008",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.048121",
                    "ticker_sentiment_score": "0.110339",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.0361",
                    "ticker_sentiment_score": "0.058552",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PLD",
                    "relevance_score": "0.006019",
                    "ticker_sentiment_score": "0.074127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FDX",
                    "relevance_score": "0.0361",
                    "ticker_sentiment_score": "0.045972",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "O",
                    "relevance_score": "0.006019",
                    "ticker_sentiment_score": "0.074127",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer - Nanobiotix  ( NASDAQ:NBTX ) ",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34987056/nanobiotix-announces-presentation-of-first-data-from-phase-1-study-evaluating-nbtxr3-for-patients-",
            "time_published": "20230928T201500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Preliminary data show local endoscopic injection of NBTXR3 followed by radiotherapy activation remains feasible with a tolerable safety profile in 15 patients As of the data cutoff, in 13 patients evaluable for efficacy, the study showed an injected tumor disease control rate of 92.3% ( 12/13 )",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.105838,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.380374",
                    "ticker_sentiment_score": "0.08077",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LIAN",
                    "relevance_score": "0.024749",
                    "ticker_sentiment_score": "0.092744",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.024749",
                    "ticker_sentiment_score": "0.015093",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer",
            "url": "https://www.globenewswire.com/news-release/2023/09/28/2751640/0/en/NANOBIOTIX-Announces-Presentation-of-First-Data-From-Phase-1-Study-Evaluating-NBTXR3-for-Patients-With-Locally-Advanced-Pancreatic-Cancer.html",
            "time_published": "20230928T201500",
            "authors": [
                "Nanobiotix S.A."
            ],
            "summary": "Data presented at the 2023 Special Meeting on Pancreatic Cancer of the American Association for Cancer Research ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.089542,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.365389",
                    "ticker_sentiment_score": "0.086295",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LIAN",
                    "relevance_score": "0.023696",
                    "ticker_sentiment_score": "0.092274",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.023696",
                    "ticker_sentiment_score": "0.020646",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NANO",
                    "relevance_score": "0.023696",
                    "ticker_sentiment_score": "-0.106131",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Anti-obesity Drug Market Is About to Get More Crowded",
            "url": "https://www.thedailyupside.com/industries/the-anti-obesity-drug-market-is-about-to-get-more-crowded/",
            "time_published": "20230928T143133",
            "authors": [
                "Griffin Kelly"
            ],
            "summary": "Obesity is an epidemic that affects more than 40% of all American adults, and it's creating a feeding frenzy for investors. With the rise of...",
            "banner_image": null,
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.thedailyupside.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.004809,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.091162",
                    "ticker_sentiment_score": "-0.078458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.091162",
                    "ticker_sentiment_score": "-0.02647",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.181137",
                    "ticker_sentiment_score": "-0.109422",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.091162",
                    "ticker_sentiment_score": "-0.078458",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs - AstraZeneca  ( NASDAQ:AZN ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34977352/pharma-giants-shift-stance-embrace-medicare-negotiations-amid-rising-drug-costs",
            "time_published": "20230928T141956",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "AstraZeneca Plc AZN, Bristol Myers Squibb & Co BMY, and Boehringer Ingelheim are willing to participate in the initial round of Medicare drug price negotiations despite having previously sued to halt the process.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/28/pills-image_by_steve_buissinne_from_pixabay.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.169527,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.56415",
                    "ticker_sentiment_score": "0.325881",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.303175",
                    "ticker_sentiment_score": "0.293044",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.303175",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Dividend Kings With Recession-Proof Payouts",
            "url": "https://realmoney.thestreet.com/investing/stocks/3-dividend-kings-with-recession-proof-payouts-16134258",
            "time_published": "20230928T141500",
            "authors": [
                "Bob Ciura"
            ],
            "summary": "3 Dividend Kings With ...",
            "banner_image": "http://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/b8f279ba-85c6-11ec-907f-7d034b5540d3.jpg",
            "source": "The Street",
            "category_within_source": "GoogleRSS",
            "source_domain": "realmoney.thestreet.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.246661,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CL",
                    "relevance_score": "0.21686",
                    "ticker_sentiment_score": "0.343959",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CURN",
                    "relevance_score": "0.087663",
                    "ticker_sentiment_score": "0.075022",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HRL",
                    "relevance_score": "0.087663",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.21686",
                    "ticker_sentiment_score": "0.018532",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now",
            "url": "https://www.zacks.com/stock/news/2157159/heres-why-you-should-retain-medtronic-mdt-stock-for-now",
            "time_published": "20230928T134900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Investors are optimistic about Medtronic (MDT) on strong global expansion.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.238528,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HQY",
                    "relevance_score": "0.195025",
                    "ticker_sentiment_score": "0.041895",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ITGR",
                    "relevance_score": "0.195025",
                    "ticker_sentiment_score": "0.141038",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.085209",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.085209",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NUVA",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.085209",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.085209",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.50287",
                    "ticker_sentiment_score": "0.386121",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.195025",
                    "ticker_sentiment_score": "0.078431",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jjs-lung-cancer-therapy-combo-succeeds-late-stage-study-2023-09-28/",
            "time_published": "20230928T133200",
            "authors": [
                "Reuters"
            ],
            "summary": "The logo of Johnson & Johnson is seen on the top of a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/B24XU6OSOBJXFBIFNFET5B53XM.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.02693,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.232439",
                    "ticker_sentiment_score": "-0.070062",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Landmark Phase 3 MARIPOSA Study Meets Primary Endpoint Resulting in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival for RYBREVANT®  ( amivantamab-vmjw )  plus Lazertinib Versus Osimertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer",
            "url": "https://www.prnewswire.com/news-releases/landmark-phase-3-mariposa-study-meets-primary-endpoint-resulting-in-statistically-significant-and-clinically-meaningful-improvement-in-progression-free-survival-for-rybrevant-amivantamab-vmjw-plus-lazertinib-versus-osimertinib--301941646.html",
            "time_published": "20230928T113000",
            "authors": [
                "The Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Landmark Phase 3 MARIPOSA Study Meets Primary Endpoint Resulting in Statistically Significant and Clinically ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.004847,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.082272",
                    "ticker_sentiment_score": "0.01986",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations",
            "url": "https://www.cnbc.com/2023/09/27/diabetes-medicare-drug-price-negotiations.html",
            "time_published": "20230927T195522",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "AstraZeneca, Boehringer Ingelheim and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107294456-1693489275735-gettyimages-1647279478-030a1107_yizu3aax.jpeg?v=1695844522&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.069057,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.262052",
                    "ticker_sentiment_score": "-0.065977",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "-0.182524",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "-0.182524",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Almost 1,500 high-grade corporate bonds are on sale. Here's how you could add cheap Apple bonds to your portfolio.",
            "url": "https://www.marketwatch.com/story/almost-1-500-high-grade-corporate-bonds-are-on-sale-heres-how-you-could-add-cheap-apple-bonds-to-your-portfolio-11cee2f6",
            "time_published": "20230927T183300",
            "authors": [
                "Ciara Linnane"
            ],
            "summary": "Almost 1,500 high-grade corporate bonds issued by some household names are currently trading between 50 and 80 cents on the dollar.",
            "banner_image": "https://images.mktw.net/im-858152?width=700&height=394",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.139351,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "-0.039136",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "-0.045583",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.300525",
                    "ticker_sentiment_score": "-0.019915",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.043979",
                    "ticker_sentiment_score": "-0.042877",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.135325",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Immunovant Stock Is Bolting Higher Today",
            "url": "https://www.fool.com/investing/2023/09/27/why-immunovant-stock-is-bolting-higher-today/",
            "time_published": "20230927T162154",
            "authors": [
                "George Budwell"
            ],
            "summary": "The company may have best-in-class autoimmune disease therapy under its roof.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.197417,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IMVT",
                    "relevance_score": "0.726873",
                    "ticker_sentiment_score": "0.307666",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ARGX",
                    "relevance_score": "0.108958",
                    "ticker_sentiment_score": "0.102277",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROIV",
                    "relevance_score": "0.41627",
                    "ticker_sentiment_score": "0.257798",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.108958",
                    "ticker_sentiment_score": "0.102277",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34953236/looking-at-johnson-johnsons-recent-unusual-options-activity",
            "time_published": "20230927T153208",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.141295,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BCS",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "-0.129342",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.784902",
                    "ticker_sentiment_score": "0.210033",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The Kellogg Split",
            "url": "https://www.fool.com/investing/2023/09/27/the-kellogg-split/",
            "time_published": "20230927T131200",
            "authors": [
                "Motley Fool Staff"
            ],
            "summary": "Kellogg is spinning off its core cereal business to focus on the fast-growing snacks market.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999987"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.100614,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GIS",
                    "relevance_score": "0.008862",
                    "ticker_sentiment_score": "0.016633",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BYND",
                    "relevance_score": "0.008862",
                    "ticker_sentiment_score": "0.024087",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.008862",
                    "ticker_sentiment_score": "0.025864",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.017723",
                    "ticker_sentiment_score": "0.021669",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KHC",
                    "relevance_score": "0.008862",
                    "ticker_sentiment_score": "0.109393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.017723",
                    "ticker_sentiment_score": "0.021669",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.008862",
                    "ticker_sentiment_score": "0.109393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "K",
                    "relevance_score": "0.141051",
                    "ticker_sentiment_score": "0.096176",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Evergreening: Big Pharma's big con",
            "url": "https://theweek.com/health/evergreening-big-pharmas-big-con",
            "time_published": "20230927T101324",
            "authors": [
                "The Week Staff"
            ],
            "summary": "A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek. You will receive a verification email shortly. There was a problem. Please refresh the page and try again.",
            "banner_image": "https://cdn.mos.cms.futurecdn.net/pwn2JSXdjJw7AwoUGZ3StA-415-80.jpg",
            "source": "The Week News",
            "category_within_source": "n/a",
            "source_domain": "theweek.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.072484,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "FRNWF",
                    "relevance_score": "0.037446",
                    "ticker_sentiment_score": "0.056402",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.037446",
                    "ticker_sentiment_score": "-0.002905",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Things About Johnson & Johnson That Smart Investors Know",
            "url": "https://www.fool.com/investing/2023/09/27/3-things-about-j-and-j-that-smart-investors-know/",
            "time_published": "20230927T093000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "J&J shares have missed out on the market rally so far this year.",
            "banner_image": "https://media.ycharts.com/charts/090480ee80ea9e10e330ca39c57c4dba.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99676"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.614606"
                }
            ],
            "overall_sentiment_score": 0.373346,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.110717",
                    "ticker_sentiment_score": "0.161755",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.110717",
                    "ticker_sentiment_score": "0.146246",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Stock Moves -0.77%: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2155700/johnson-johnson-jnj-stock-moves--077-what-you-should-know",
            "time_published": "20230926T214519",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) closed the most recent trading day at $159.02, moving -0.77% from the previous trading session.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default178.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.078024,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.48268",
                    "ticker_sentiment_score": "0.04361",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749941/0/en/NANOBIOTIX-Provides-Business-Update-and-Financial-Results-for-the-First-Half-of-2023.html",
            "time_published": "20230926T201500",
            "authors": [
                "Nanobiotix S.A."
            ],
            "summary": "Conference call and webcast scheduled for Wednesday, September 27, 2023, at 2:00 pm CEST / 8:00 am ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.989041"
                }
            ],
            "overall_sentiment_score": 0.158153,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.308807",
                    "ticker_sentiment_score": "0.17779",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LIAN",
                    "relevance_score": "0.027555",
                    "ticker_sentiment_score": "0.130376",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.055078",
                    "ticker_sentiment_score": "0.083017",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NANO",
                    "relevance_score": "0.01378",
                    "ticker_sentiment_score": "0.009553",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cataract Surgery Devices And Equipment Market Analysis 2023-2027: Projected Market Size, Key Drivers, And Major Segments As Per The Business Research Company's Cataract Surgery Devices And Equipment Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34915104/cataract-surgery-devices-and-equipment-market-analysis-2023-2027-projected-market-size-key-drivers",
            "time_published": "20230926T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Cataract Surgery Devices And Equipment Global Market Report 2023, the global cataract surgery devices and equipment market is on a remarkable growth trajectory, with a projected market size of $7.11 billion in ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.260293,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALC",
                    "relevance_score": "0.059194",
                    "ticker_sentiment_score": "0.106999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.118064",
                    "ticker_sentiment_score": "0.122673",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.059194",
                    "ticker_sentiment_score": "0.106999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STAA",
                    "relevance_score": "0.059194",
                    "ticker_sentiment_score": "0.106999",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Endoscopy Procedures Market Size worth $53.19 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34912197/endoscopy-procedures-market-size-worth-53-19-billion-globally-by-2030-exclusive-report-by-the-insi",
            "time_published": "20230926T143528",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Pune, India, Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- Endoscopy is a minimally invasive procedure used to examine a person's digestive tract through the mouth, anus, or in small incisions. The procedure uses an endoscope, a flexible tube with a light and camera attached.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.161534,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SNEJF",
                    "relevance_score": "0.065595",
                    "ticker_sentiment_score": "0.095133",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMSI",
                    "relevance_score": "0.032825",
                    "ticker_sentiment_score": "0.143827",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.032825",
                    "ticker_sentiment_score": "0.143827",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.032825",
                    "ticker_sentiment_score": "0.143827",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.032825",
                    "ticker_sentiment_score": "0.143827",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.065595",
                    "ticker_sentiment_score": "0.182441",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CNMD",
                    "relevance_score": "0.032825",
                    "ticker_sentiment_score": "0.143827",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Monster Stocks to Buy Without Any Hesitation",
            "url": "https://www.fool.com/investing/2023/09/26/2-monster-stocks-to-buy-without-any-hesitation/",
            "time_published": "20230926T114100",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "Recent bumps in the road won't deter these companies.",
            "banner_image": "https://media.ycharts.com/charts/bf3239a52945726203afde3d89eccd2d.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.251048,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.071998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.224383",
                    "ticker_sentiment_score": "0.281205",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.478692",
                    "ticker_sentiment_score": "0.313658",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation - Avalo Therapeutics  ( NASDAQ:AVTX ) , Horizon Tech Finance  ( NASDAQ:HRZN ) ",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34899423/avalo-therapeutics-successfully-eliminates-35-million-debt-paving-the-way-for-future-growth-and-in",
            "time_published": "20230926T110000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- In a major achievement, Avalo Therapeutics AVTX proudly announces the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance Corporation HRZN. This significant milestone not only signifies the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.262621,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MRCC",
                    "relevance_score": "0.074692",
                    "ticker_sentiment_score": "0.097972",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLDX",
                    "relevance_score": "0.037387",
                    "ticker_sentiment_score": "0.119603",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.037387",
                    "ticker_sentiment_score": "0.119603",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVTX",
                    "relevance_score": "0.426225",
                    "ticker_sentiment_score": "0.40603",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "HRZN",
                    "relevance_score": "0.29234",
                    "ticker_sentiment_score": "0.381153",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.037387",
                    "ticker_sentiment_score": "0.119603",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749320/0/en/Avalo-Therapeutics-Successfully-Eliminates-35-Million-Debt-Paving-the-Way-for-Future-Growth-and-Innovation.html",
            "time_published": "20230926T110000",
            "authors": [
                "Avalo Therapeutics"
            ],
            "summary": "WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- In a major achievement, Avalo Therapeutics ( Nasdaq: AVTX ) proudly announces the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance Corporation ( Nasdaq: HRZN ) .",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                }
            ],
            "overall_sentiment_score": 0.201841,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MRCC",
                    "relevance_score": "0.057352",
                    "ticker_sentiment_score": "0.097099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLDX",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.115436",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.115436",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVTX",
                    "relevance_score": "0.307661",
                    "ticker_sentiment_score": "0.341524",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HRZN",
                    "relevance_score": "0.226477",
                    "ticker_sentiment_score": "0.321381",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.115436",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help Transform Singapore's Life Science Innovation Ecosystem",
            "url": "https://www.prnewswire.com/apac/news-releases/johnson--johnson-innovation-announces-collaboration-with-singapore-economic-development-board-to-help-transform-singapores-life-science-innovation-ecosystem-301938094.html",
            "time_published": "20230925T223000",
            "authors": [
                "Johnson & Johnson Innovation LLC"
            ],
            "summary": "Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2219093/Johnson_Johnson_Innovation_JLABS_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.325298,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.683587",
                    "ticker_sentiment_score": "0.458931",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/electrophysiology-catheters-market-size-to-grow-by-usd-2-24-billion-from-2022-2027-abbott-laboratories-acutus-medical-inc-and-johnson-and-johnson-are-some-of-the-major-companies-in-the-market---technavio-301936344.html",
            "time_published": "20230925T211500",
            "authors": [],
            "summary": "Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.316334,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AFIB",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMSI",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NHNKF",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.074271",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATRC",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SEMHF",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCRPF",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHG",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.070037",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",
            "url": "https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html",
            "time_published": "20230925T210100",
            "authors": [
                "LLP",
                "DelveInsight Business Research"
            ],
            "summary": "CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.0762,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SRNEQ",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.019103",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLUE",
                    "relevance_score": "0.05623",
                    "ticker_sentiment_score": "0.056937",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.026387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLYYF",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.057813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.028556",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVBXF",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWTX",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.024665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DTIL",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRTHF",
                    "relevance_score": "0.130723",
                    "ticker_sentiment_score": "0.064024",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRBU",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.057813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCCC",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.026387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MBIO",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PSTX",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.05738",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BGNE",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.026387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ASPHF",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.024665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SANA",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.024665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALNY",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.029512",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLCM",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CASI",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ITOS",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.024665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.130723",
                    "ticker_sentiment_score": "0.049466",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLLS",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.05738",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACLX",
                    "relevance_score": "0.09358",
                    "ticker_sentiment_score": "0.057751",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALLO",
                    "relevance_score": "0.05623",
                    "ticker_sentiment_score": "0.045942",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JWCTF",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.024665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SZIHF",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.014356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATRA",
                    "relevance_score": "0.018757",
                    "ticker_sentiment_score": "0.012868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "0.029512",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "18 top public-relations experts CEOs scramble to hire in a crisis",
            "url": "https://www.businessinsider.com/meet-the-top-pr-people-in-crisis-communications-2023-9",
            "time_published": "20230925T181300",
            "authors": [
                "Michael Kaminer"
            ],
            "summary": "Meet the Top PR People in Crisis Communications - Business Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.businessinsider.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": -0.090012,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOLD",
                    "relevance_score": "0.022431",
                    "ticker_sentiment_score": "-0.002845",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.022431",
                    "ticker_sentiment_score": "-0.156203",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NEM",
                    "relevance_score": "0.022431",
                    "ticker_sentiment_score": "-0.002845",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLESY",
                    "relevance_score": "0.022431",
                    "ticker_sentiment_score": "-0.079229",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.022431",
                    "ticker_sentiment_score": "-0.156203",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.022431",
                    "ticker_sentiment_score": "0.074731",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRDCF",
                    "relevance_score": "0.022431",
                    "ticker_sentiment_score": "0.074731",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": " ( JNJ )  - Analyzing Johnson & Johnson's Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/short-sellers/23/09/34870469/jnj-analyzing-johnson-johnsons-short-interest",
            "time_published": "20230925T153024",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Johnson & Johnson's JNJ short percent of float has fallen 58.36% since its last report. The company recently reported that it has 32.86 million shares sold short, which is 1.37% of all regular shares that are available for trading.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.237013,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.081322",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Invesco Pharmaceuticals ETF  ( PJP ) ?",
            "url": "https://www.zacks.com/stock/news/2154633/should-you-invest-in-the-invesco-pharmaceuticals-etf-pjp",
            "time_published": "20230925T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default85.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.164233,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.196877",
                    "ticker_sentiment_score": "0.100763",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Consumer Healthcare Market to grow by USD 189.13 billion from 2022 to 2027, North America to account for 33% of ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/consumer-healthcare-market-to-grow-by-usd-189-13-billion-from-2022-to-2027--north-america-to-account-for-33-of-market-growth--technavio-301935802.html",
            "time_published": "20230924T203500",
            "authors": [],
            "summary": "Consumer Healthcare Market to grow by USD 189.13 billion from 2022 to 2027, North America to account for 33% of ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.155259,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABT",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HLF",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "K",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GLAPF",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NSRGF",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RBGPF",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Once reputation is at risk, so is money. That's when companies turn to crisis PR | Business",
            "url": "https://www.cnn.com/2023/09/24/business/crisis-public-relations-companies/index.html",
            "time_published": "20230924T173700",
            "authors": [
                "Eva Rothenberg"
            ],
            "summary": "Once reputation is at risk, so is money. That's when companies turn to crisis PR ...",
            "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/230404194537-01-bud-light-mulvaney.jpg?c=16x9&q=h_720,w_1280,c_fill",
            "source": "CNN",
            "category_within_source": "Markets",
            "source_domain": "www.cnn.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": -0.080403,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WBD",
                    "relevance_score": "0.022452",
                    "ticker_sentiment_score": "0.035095",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.022452",
                    "ticker_sentiment_score": "-0.003612",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.022452",
                    "ticker_sentiment_score": "-0.059573",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.022452",
                    "ticker_sentiment_score": "-0.10054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.022452",
                    "ticker_sentiment_score": "-0.045261",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Best Stocks to Buy in September and Hold Forever",
            "url": "https://www.fool.com/investing/2023/09/24/3-best-stocks-to-buy-in-september-and-hold-forever/",
            "time_published": "20230924T114100",
            "authors": [
                "Justin Pope"
            ],
            "summary": "Healthcare blue chip stocks with proven track records can be excellent long-term investments.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.195843,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.218325",
                    "ticker_sentiment_score": "0.181788",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.322374",
                    "ticker_sentiment_score": "0.161138",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.055236",
                    "ticker_sentiment_score": "0.027074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.110209",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.164656",
                    "ticker_sentiment_score": "0.017636",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Laparoscopic Devices Market to grow by USD 4.39 billion from 2022-2027, North America to account for 36% of market ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/laparoscopic-devices-market-to-grow-by-usd-4-39-billion-from-2022-2027--north-america-to-account-for-36-of-market-growth---technavio-301935797.html",
            "time_published": "20230924T103500",
            "authors": [],
            "summary": "Laparoscopic Devices Market to grow by USD 4.39 billion from 2022-2027, North America to account for 36% of market ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.254084,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "COO",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.108466",
                    "ticker_sentiment_score": "0.110819",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.108466",
                    "ticker_sentiment_score": "0.132623",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFX",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HOCPF",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMDIF",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BDX",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.108466",
                    "ticker_sentiment_score": "0.132623",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNMD",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Flow Diversion Aneurysm Treatment Market to grow by USD 2.11 billion from 2022 to 2027, North America to account ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/flow-diversion-aneurysm-treatment-market-to-grow-by-usd-2-11-billion-from-2022-to-2027--north-america-to-account-for-38-of-market-growth---technavio-301935772.html",
            "time_published": "20230924T014500",
            "authors": [],
            "summary": "Flow Diversion Aneurysm Treatment Market to grow by USD 2.11 billion from 2022 to 2027, North America to account ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.188521,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NSPR",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SMAWF",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRUMF",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEN",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCRPF",
                    "relevance_score": "0.051003",
                    "ticker_sentiment_score": "0.112393",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global LASIK Eye Surgery Devices Market Analysis Report 2023-2028: Medical Tourism and LASIK Surgery as the Preferred Treatment for Refractive Errors Bolsters Growth",
            "url": "https://www.prnewswire.com/news-releases/global-lasik-eye-surgery-devices-market-analysis-report-2023-2028-medical-tourism-and-lasik-surgery-as-the-preferred-treatment-for-refractive-errors-bolsters-growth-301936095.html",
            "time_published": "20230922T230000",
            "authors": [
                "Research and Markets"
            ],
            "summary": "Global LASIK Eye Surgery Devices Market Analysis Report 2023-2028: Medical Tourism and LASIK Surgery as the ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.240897,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALC",
                    "relevance_score": "0.143415",
                    "ticker_sentiment_score": "0.093836",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLCO",
                    "relevance_score": "0.143415",
                    "ticker_sentiment_score": "0.093836",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.143415",
                    "ticker_sentiment_score": "0.093836",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Innovative Gelatin Capsules Transforming Pharmaceutical Industry: A Look into the Future",
            "url": "https://www.prnewswire.com/news-releases/innovative-gelatin-capsules-transforming-pharmaceutical-industry-a-look-into-the-future-301936082.html",
            "time_published": "20230922T214500",
            "authors": [
                "Research and Markets"
            ],
            "summary": "DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The \"Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Source, By Function, By End Use, By Regions, Segment Forecast, 2023-2032\" report has been added to ResearchAndMarkets.com's offering.",
            "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.269668,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.055999",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global Dermatology Drugs Market Set to Skyrocket, Anticipated Valuation of $50.47 Billion by 2032",
            "url": "https://www.prnewswire.com/news-releases/global-dermatology-drugs-market-set-to-skyrocket-anticipated-valuation-of-50-47-billion-by-2032--301936081.html",
            "time_published": "20230922T213000",
            "authors": [
                "Research and Markets"
            ],
            "summary": "DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The \"Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area, By Drug Class, By Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2023-2032\" report has been added to ResearchAndMarkets.com's ...",
            "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.263166,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.056",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Executive Leadership Council to Award More Than $3M in Scholarships During its Annual Recognition and Fundraising Gala",
            "url": "https://www.prnewswire.com/news-releases/the-executive-leadership-council-to-award-more-than-3m-in-scholarships-during-its-annual-recognition-and-fundraising-gala-301936374.html",
            "time_published": "20230922T160500",
            "authors": [
                "The Executive Leadership Council"
            ],
            "summary": "The Executive Leadership Council to Award More Than $3M in Scholarships During its Annual Recognition and ... PR ...",
            "banner_image": "http://photos.prnewswire.com/prnthumb/20160706/386761LOGO",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.393585,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.264927",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.166788",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CHH",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.107736",
                    "ticker_sentiment_score": "0.1888",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCO",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPE",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.053992",
                    "ticker_sentiment_score": "0.043822",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority  ( BARDA ) ",
            "url": "https://www.prnewswire.com/news-releases/asha-therapeutics-selected-as-a-blue-knight-company-by-johnson--johnson-innovation-and-the-biomedical-advanced-research-and-development-authority-barda-301936211.html",
            "time_published": "20230922T140300",
            "authors": [
                "Asha Therapeutics"
            ],
            "summary": "Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2218312/Asha_Therapeutics_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.275257,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BX",
                    "relevance_score": "0.12013",
                    "ticker_sentiment_score": "0.130348",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.179343",
                    "ticker_sentiment_score": "0.230915",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "FORTUNE CEO INITIATIVE RETURNS TO WASHINGTON, D.C. OCTOBER 3, 2023",
            "url": "https://www.prnewswire.com/news-releases/fortune-ceo-initiative-returns-to-washington-dc-october-3-2023-301936220.html",
            "time_published": "20230922T140000",
            "authors": [
                "Fortune Media (USA) Corporation"
            ],
            "summary": "Navigating the New Frontier of Leadership: Fortune's annual meeting of the CEO Initiative will assemble top leaders in business, public affairs and government to examine crucial issues of AI, ESG, culture wars, geopolitical tensions, and other industry headwinds Confirmed speakers include U.S.",
            "banner_image": "https://mma.prnewswire.com/media/2167808/fortune_logo_black_ID_e110fdae6750_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.438105,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ACN",
                    "relevance_score": "0.073098",
                    "ticker_sentiment_score": "0.128025",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.073098",
                    "ticker_sentiment_score": "0.213124",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.073098",
                    "ticker_sentiment_score": "0.128025",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Here is What to Know Beyond Why Johnson & Johnson  ( JNJ )  is a Trending Stock",
            "url": "https://www.zacks.com/stock/news/2154107/here-is-what-to-know-beyond-why-johnson-johnson-jnj-is-a-trending-stock",
            "time_published": "20230922T130012",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default38.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                }
            ],
            "overall_sentiment_score": 0.226164,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.477606",
                    "ticker_sentiment_score": "0.138942",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The 'Great IPO Reopening' may be on hold: rising rates and weaker stocks are a killer",
            "url": "https://www.cnbc.com/2023/09/22/ipo-reopening-is-on-hold-rising-rates-and-lower-stocks-are-a-killer.html",
            "time_published": "20230922T123921",
            "authors": [
                "Bob Pisani"
            ],
            "summary": "Cash-strapped unicorns have three choices: raise additional capital in the private markets, merge or be bought out. move into the public markets.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106097508-1566850820460gettyimages-458005228.jpeg?v=1695386361&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Finance",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.99489"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": -0.034034,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "-0.10008",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "-0.10008",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "StockNews.com Downgrades Johnson & Johnson  ( NYSE:JNJ )  to Buy",
            "url": "https://www.defenseworld.net/2023/09/22/stocknews-com-downgrades-johnson-johnson-nysejnj-to-buy-2.html",
            "time_published": "20230922T062642",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a \"strong-buy\" rating to a \"buy\" rating in a research note issued to investors on Wednesday. Other analysts also recently issued reports about the company.",
            "banner_image": "https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.255369,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BCS",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.033866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FDX",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.0894",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.74896",
                    "ticker_sentiment_score": "0.407233",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Osteal Therapeutics Closes $23M Series C Financing",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34790133/osteal-therapeutics-closes-23m-series-c-financing",
            "time_published": "20230921T122326",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Financing led by Asteroid Partners with new investor Gideon Strategic Partners and returning investors Johnson and Johnson Development Corp., HM Capital, Prism Ventures and Medvest Capital.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.195924,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.080055",
                    "ticker_sentiment_score": "0.149718",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "This Cancer Therapy is Lifesaving, but There Isn't Enough of It",
            "url": "https://www.wsj.com/health/pharma/blockbuster-cancer-treatment-stymied-by-supply-chainfor-now-92723823",
            "time_published": "20230921T120000",
            "authors": [
                "David Wainer"
            ],
            "summary": "A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing.",
            "banner_image": "https://images.wsj.net/im-856224?width=700&height=466",
            "source": "Wall Street Journal",
            "category_within_source": "Markets",
            "source_domain": "www.wsj.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.015142,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.716023",
                    "ticker_sentiment_score": "-0.37182",
                    "ticker_sentiment_label": "Bearish"
                }
            ]
        },
        {
            "title": "Global Soft Tissue Repair Market size to grow by USD 3.42 billion from 2022-2027 | 3M Co., Acera Surgical Inc., and ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/global-soft-tissue-repair-market-size-to-grow-by-usd-3-42-billion-from-2022-2027--3m-co-acera-surgical-inc-and-allosource-are-some-leading-market-companies---technavio-301934252.html",
            "time_published": "20230921T083500",
            "authors": [],
            "summary": "Global Soft Tissue Repair Market size to grow by USD 3.42 billion from 2022-2027 | 3M Co., Acera Surgical Inc., and ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.399538,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BDX",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IART",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.105836",
                    "ticker_sentiment_score": "0.148391",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNMD",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AORT",
                    "relevance_score": "0.053035",
                    "ticker_sentiment_score": "0.117649",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer",
            "url": "https://www.globenewswire.com/news-release/2023/09/21/2746967/0/en/Faron-Appoints-Dr-Birge-Berns-MD-as-Interim-Chief-Medical-Officer.html",
            "time_published": "20230921T060000",
            "authors": [
                "Faron Pharmaceuticals Oy"
            ],
            "summary": "• Dr. Marie-Louise Fjällskog, outgoing CMO, is proposed to continue key role in bexmarilimab's development as a Board member ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/ae344e9a-bc8e-4213-833f-0c0c97b7d047",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.220352,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.021214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.036037",
                    "ticker_sentiment_score": "0.04841",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34778753/faron-appoints-dr-birge-berns-md-as-interim-chief-medical-officer",
            "time_published": "20230921T060000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "• Dr. Marie-Louise Fjällskog, outgoing CMO, is proposed to continue key role in bexmarilimab's development as a Board member TURKU, Finland and BOSTON, Sept. 21, 2023 ( GLOBE NEWSWIRE ) -- Faron Pharmaceuticals Ltd.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.217968,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.071892",
                    "ticker_sentiment_score": "0.021211",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.035983",
                    "ticker_sentiment_score": "0.048399",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34772994/johnson-johnson-unusual-options-activity",
            "time_published": "20230920T201541",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.098928,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MS",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.822",
                    "ticker_sentiment_score": "0.263241",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: Morris Kandinov Investigating EBS, JRVR, EGIO, and HAFC; Shareholders are Encouraged to Contact the Firm",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34771758/shareholder-alert-morris-kandinov-investigating-ebs-jrvr-egio-and-hafc-shareholders-are-encouraged",
            "time_published": "20230920T190955",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "SAN DIEGO, Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Emergent BioSolutions Inc., James River Group Holdings, Ltd., Edgio, Inc., and Hanmi Financial Corporation.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": -0.036585,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "EGIO",
                    "relevance_score": "0.187827",
                    "ticker_sentiment_score": "-0.034709",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.047371",
                    "ticker_sentiment_score": "-0.066999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JRVR",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "-0.046772",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EBS",
                    "relevance_score": "0.322474",
                    "ticker_sentiment_score": "-0.11929",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HAFC",
                    "relevance_score": "0.094576",
                    "ticker_sentiment_score": "0.056029",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.094576",
                    "ticker_sentiment_score": "-0.072926",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/nulogy-and-omp-expand-partnership-to-deliver-digital-transformation-experience-to-life-sciences-and-chemical-supply-chains-301932200.html",
            "time_published": "20230920T143000",
            "authors": [],
            "summary": "Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.390657,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CL",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.068745",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.068745",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.334982",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.334982",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical Supply Chains",
            "url": "https://www.benzinga.com/pressreleases/23/09/n34765517/nulogy-and-omp-expand-partnership-to-deliver-digital-transformation-experience-to-life-sciences-an",
            "time_published": "20230920T143000",
            "authors": [
                "PRNewswire"
            ],
            "summary": "The companies are expanding their collaboration, offering their combined solutions and services to additional industries to fulfill their growing need for digital transformation of internal planning and external supplier network collaboration.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.384446,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CL",
                    "relevance_score": "0.05257",
                    "ticker_sentiment_score": "0.068658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.05257",
                    "ticker_sentiment_score": "0.068658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05257",
                    "ticker_sentiment_score": "0.334926",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.05257",
                    "ticker_sentiment_score": "0.334926",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical ... - Canada NewsWire",
            "url": "https://www.newswire.ca/news-releases/nulogy-and-omp-expand-partnership-to-deliver-digital-transformation-experience-to-life-sciences-and-chemical-supply-chains-834338237.html",
            "time_published": "20230920T143000",
            "authors": [],
            "summary": "Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical ... Canada ...",
            "banner_image": null,
            "source": "Canada Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.newswire.ca",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.385019,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CL",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.068341",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.068341",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.334553",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.334553",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here are the 14 stocks Jim Cramer is watching, including Apple, Goldman Sachs, Amazon",
            "url": "https://www.cnbc.com/2023/09/20/here-are-the-14-stocks-jim-cramer-is-watching-including-apple-goldman-sachs-amazon.html",
            "time_published": "20230920T134114",
            "authors": [
                "Jim Cramer"
            ],
            "summary": "Here are some of the tickers on my radar for Wednesday, Sept. 20, taken directly from my reporter's notebook.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106088318-1566320944636apple-card-available-today-card-on-iphonexs-screen-082019.jpg?v=1695217274&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.307036,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PYPL",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.373947",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.283323",
                    "ticker_sentiment_score": "0.161249",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.096283",
                    "ticker_sentiment_score": "0.203064",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DG",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.00624",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.096283",
                    "ticker_sentiment_score": "0.333037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.096283",
                    "ticker_sentiment_score": "0.004303",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.292977",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.11851",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GIS",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "-0.136642",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LEN",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.303035",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VTR",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.169373",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZO",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.318002",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CHWY",
                    "relevance_score": "0.283323",
                    "ticker_sentiment_score": "-0.184993",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.292977",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PINS",
                    "relevance_score": "0.283323",
                    "ticker_sentiment_score": "0.487995",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.456985",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Thrombectomy Devices Market worth $2.1 Billion by 2027 - Exclusive Report by The Insight Partners",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34761070/thrombectomy-devices-market-worth-2-1-billion-by-2027-exclusive-report-by-the-insight-partners",
            "time_published": "20230920T130929",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Pune, India., Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- The thrombectomy devices market growth is propelled by elevating incidences of CVDs and neurological diseases, technological advancements, government initiatives towards prevention of diseases and favorable medical reimbursement scenario.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.246158,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SYK",
                    "relevance_score": "0.088472",
                    "ticker_sentiment_score": "0.127632",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRUMF",
                    "relevance_score": "0.044304",
                    "ticker_sentiment_score": "0.121324",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.088472",
                    "ticker_sentiment_score": "0.110876",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFX",
                    "relevance_score": "0.044304",
                    "ticker_sentiment_score": "0.121324",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEN",
                    "relevance_score": "0.088472",
                    "ticker_sentiment_score": "0.091518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.088472",
                    "ticker_sentiment_score": "0.127632",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NARI",
                    "relevance_score": "0.044304",
                    "ticker_sentiment_score": "0.121324",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "BDA Bolsters Leadership Bench with Appointment of Divisional Vice President of Global Marketing and Creative Services - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/bda-bolsters-leadership-bench-with-appointment-of-divisional-vice-president-of-global-marketing-and-creative-services-301933088.html",
            "time_published": "20230920T130000",
            "authors": [],
            "summary": "BDA Bolsters Leadership Bench with Appointment of Divisional Vice President of Global Marketing and Creative Services PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.443311,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.148273",
                    "ticker_sentiment_score": "0.35376",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "TEF",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.185037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.148273",
                    "ticker_sentiment_score": "0.217254",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VOD",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.185037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FDX",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.190116",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.148273",
                    "ticker_sentiment_score": "0.217254",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.148273",
                    "ticker_sentiment_score": "0.217254",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "2 Incredibly Cheap Dividend Stocks to Buy Now",
            "url": "https://www.fool.com/investing/2023/09/20/2-incredibly-cheap-dividend-stocks-to-buy-now/",
            "time_published": "20230920T123000",
            "authors": [
                "George Budwell"
            ],
            "summary": "High-quality dividend stocks are rarely cheap. These two names are an exception.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998356"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.256722,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.578355",
                    "ticker_sentiment_score": "0.341976",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "T",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "-0.047609",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.3333",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?",
            "url": "https://www.zacks.com/stock/news/2152866/should-you-invest-in-the-ishares-us-healthcare-etf-iyh",
            "time_published": "20230920T102007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default67.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.228879,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.066414",
                    "ticker_sentiment_score": "0.088153",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.132368",
                    "ticker_sentiment_score": "0.069712",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.132368",
                    "ticker_sentiment_score": "0.069712",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.132368",
                    "ticker_sentiment_score": "0.069712",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash",
            "url": "https://www.fool.com/investing/2023/09/20/these-2-stocks-good-hedge-against-crash/",
            "time_published": "20230920T100000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "Market crashes are inevitable, but certain stocks could limit potential damage.",
            "banner_image": "https://media.ycharts.com/charts/88ba9c1602687e247d5a0e53f960c33e.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.192392,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.551295",
                    "ticker_sentiment_score": "0.190862",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.135952",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 No-Brainer Stocks to Buy With $500 Right Now",
            "url": "https://www.fool.com/investing/2023/09/20/3-no-brainer-stocks-to-buy-with-500-right-now/",
            "time_published": "20230920T092100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "A modest amount of money can go a long way when it's invested in industry-leading businesses.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747897%2Fcash-money-five-hundred-dollars-invest-retire-stock-market-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999365"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.17057,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.062271",
                    "ticker_sentiment_score": "0.141685",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.031159",
                    "ticker_sentiment_score": "0.076051",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DG",
                    "relevance_score": "0.274834",
                    "ticker_sentiment_score": "0.102797",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TDOC",
                    "relevance_score": "0.093289",
                    "ticker_sentiment_score": "0.110892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.031159",
                    "ticker_sentiment_score": "0.080101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.154852",
                    "ticker_sentiment_score": "0.159817",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Stock Moves -0.17%: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2152751/johnson-johnson-jnj-stock-moves--017-what-you-should-know",
            "time_published": "20230919T214520",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) closed the most recent trading day at $162.20, moving -0.17% from the previous trading session.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default20.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.11131,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.658245",
                    "ticker_sentiment_score": "0.121668",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Danaher Lowers Price Of Tuberculosis Test After Pressure Campaign",
            "url": "https://www.forbes.com/sites/willskipworth/2023/09/19/danaher-lowers-price-of-tuberculosis-test-after-pressure-campaign/",
            "time_published": "20230919T195341",
            "authors": [
                "William Skipworth"
            ],
            "summary": "Popular novelist and YouTuber John Green as well as international health nonprofits had been running a weeklong pressure campaign against the company.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/6509f7d391350da2de59e641/0x0.jpg?format=jpg&crop=4139,2330,x0,y111,safe&width=1200",
            "source": "Forbes",
            "category_within_source": "Business",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.083244,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.11894",
                    "ticker_sentiment_score": "0.052364",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.11894",
                    "ticker_sentiment_score": "0.052364",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "An Update On The Foreign Tax Credit Rules And IRS Relief",
            "url": "https://www.forbes.com/sites/taxnotes/2023/09/19/an-update-on-the-foreign-tax-credit-rules-and-irs-relief/",
            "time_published": "20230919T194640",
            "authors": [
                "Tax Notes Staff"
            ],
            "summary": "Tax Notes reporter Andrew Velarde discusses the latest developments on the final regulations for claiming foreign tax credits, including the IRS's decision to delay implementation and the tax community's response.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/647787f46408660fcda62ddd/0x0.jpg?format=jpg&width=1200",
            "source": "Forbes",
            "category_within_source": "Money",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.208444,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.025008",
                    "ticker_sentiment_score": "0.010301",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VMW",
                    "relevance_score": "0.025008",
                    "ticker_sentiment_score": "0.088376",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.025008",
                    "ticker_sentiment_score": "0.088376",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "OXOS Medical taps medtech transformational leader Jeff Brown as COO",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34729402/oxos-medical-taps-medtech-transformational-leader-jeff-brown-as-coo",
            "time_published": "20230919T133043",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "ATLANTA, Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- OXOS Medical®, a leader in the portable x-ray solutions market, today announced that it has appointed Jeff Brown as the company's new Chief Operations Officer.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.424328,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "STE",
                    "relevance_score": "0.090474",
                    "ticker_sentiment_score": "0.064221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.090474",
                    "ticker_sentiment_score": "0.064221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.090474",
                    "ticker_sentiment_score": "0.064221",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Anixa Biosciences Establishes Cancer Business Advisory Board",
            "url": "https://www.prnewswire.com/news-releases/anixa-biosciences-establishes-cancer-business-advisory-board-301931654.html",
            "time_published": "20230919T123000",
            "authors": [
                "Inc.",
                "Anixa Biosciences"
            ],
            "summary": "SAN JOSE, Calif., Sept. 19, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ( \"Anixa\" or the \"Company\" ) ( NASDAQ: ANIX ) , a biotechnology company focused on the treatment and prevention of cancer, today announced that it has established a Cancer Business Advisory Board ( CBAB ) , whose purpose is ...",
            "banner_image": "https://mma.prnewswire.com/media/602982/ITUS_Corporation_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": -0.107487,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ANIX",
                    "relevance_score": "0.040899",
                    "ticker_sentiment_score": "-0.138826",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.020456",
                    "ticker_sentiment_score": "0.026359",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "5 Investors Make $1 Billion A Year From Dividends Alone",
            "url": "https://www.investors.com/etfs-and-funds/sectors/sp500-investors-found-a-way-to-make-billion-a-year-from-dividends/",
            "time_published": "20230919T120000",
            "authors": [
                "MATT KRANTZ",
                "Investor's Business Daily"
            ],
            "summary": "Looking to score some supersize dividends as the S&P 500 goes sideways? There's a billion lessons to be learned from investors turning dividends into serious cashflow.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/06/Stock-richpeople-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999956"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.165786,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.079524",
                    "ticker_sentiment_score": "0.035642",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.079524",
                    "ticker_sentiment_score": "0.037518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.079524",
                    "ticker_sentiment_score": "0.037518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.079524",
                    "ticker_sentiment_score": "0.037518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.079524",
                    "ticker_sentiment_score": "0.037518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.235442",
                    "ticker_sentiment_score": "0.118943",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.119038",
                    "ticker_sentiment_score": "0.086778",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Impulse Dynamics Announces Leadership Changes",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34722638/impulse-dynamics-announces-leadership-changes",
            "time_published": "20230919T111708",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "MARLTON, N.J., Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership appointments, including Jason Spees to Chief Executive Officer, Shlomi Nachman to Chairman of the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.293738,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LEIC",
                    "relevance_score": "0.023395",
                    "ticker_sentiment_score": "0.276139",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.023395",
                    "ticker_sentiment_score": "0.158925",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.04677",
                    "ticker_sentiment_score": "0.092595",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PCMC",
                    "relevance_score": "0.023395",
                    "ticker_sentiment_score": "0.015525",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.023395",
                    "ticker_sentiment_score": "0.015525",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04677",
                    "ticker_sentiment_score": "0.123094",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Stocks That Could Be Kicked Out of the Dow -- and the Companies That May Replace Them",
            "url": "https://www.fool.com/investing/2023/09/19/3-stocks-that-could-be-kicked-out-of-the-dow/",
            "time_published": "20230919T090600",
            "authors": [
                "Sean Williams"
            ],
            "summary": "Three time-tested yet poor-performing Dow components are at risk of being removed from the index.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747918%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.158609,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "-0.050033",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.129168",
                    "ticker_sentiment_score": "0.006204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.161062",
                    "ticker_sentiment_score": "0.127854",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.129168",
                    "ticker_sentiment_score": "0.204767",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.192694",
                    "ticker_sentiment_score": "0.112182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.032425",
                    "ticker_sentiment_score": "0.185748",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.032425",
                    "ticker_sentiment_score": "0.019421",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.032425",
                    "ticker_sentiment_score": "-0.046667",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSM",
                    "relevance_score": "0.032425",
                    "ticker_sentiment_score": "0.118551",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.224013",
                    "ticker_sentiment_score": "0.257241",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.097062",
                    "ticker_sentiment_score": "0.112527",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.129168",
                    "ticker_sentiment_score": "0.208321",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.032425",
                    "ticker_sentiment_score": "0.039135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRV",
                    "relevance_score": "0.032425",
                    "ticker_sentiment_score": "0.02127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CME",
                    "relevance_score": "0.032425",
                    "ticker_sentiment_score": "0.039135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.097062",
                    "ticker_sentiment_score": "0.134101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.032425",
                    "ticker_sentiment_score": "0.039135",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "ONWARD® Reports 2023 Half Year Results and Business Update",
            "url": "https://www.globenewswire.com/news-release/2023/09/19/2745268/0/en/ONWARD-Reports-2023-Half-Year-Results-and-Business-Update.html",
            "time_published": "20230919T043000",
            "authors": [
                "ONWARD Medical"
            ],
            "summary": "Eindhoven, Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7 ( 1 ) OF THE EUROPEAN MARKET ABUSE REGULATION ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/394fa020-511d-4331-9279-c835d2daf4d6",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.193677,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SCI",
                    "relevance_score": "0.256677",
                    "ticker_sentiment_score": "0.207982",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVRO",
                    "relevance_score": "0.020096",
                    "ticker_sentiment_score": "0.085159",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSNUF",
                    "relevance_score": "0.020096",
                    "ticker_sentiment_score": "0.108051",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.020096",
                    "ticker_sentiment_score": "0.108051",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.020096",
                    "ticker_sentiment_score": "0.108051",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.020096",
                    "ticker_sentiment_score": "0.085159",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors",
            "url": "https://www.globenewswire.com/news-release/2023/09/18/2745192/0/en/AnaptysBio-Announces-Appointment-of-John-Orwin-as-Chairman-of-the-Board-of-Directors.html",
            "time_published": "20230918T201500",
            "authors": [
                "Inc.",
                "AnaptysBio"
            ],
            "summary": "SAN DIEGO, Sept. 18, 2023 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ( Nasdaq: ANAB ) , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it has appointed John Orwin chairman of the AnaptysBio Board of Directors.",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/04e9e812-bf31-4349-997d-639cc0f17ebf",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.187401,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ANAB",
                    "relevance_score": "0.350564",
                    "ticker_sentiment_score": "0.120479",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TVTX",
                    "relevance_score": "0.04028",
                    "ticker_sentiment_score": "0.060892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.04028",
                    "ticker_sentiment_score": "0.060892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AFFY",
                    "relevance_score": "0.04028",
                    "ticker_sentiment_score": "0.060892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCEL",
                    "relevance_score": "0.04028",
                    "ticker_sentiment_score": "0.060892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04028",
                    "ticker_sentiment_score": "0.060892",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dwayne 'The Rock' Johnson makes WWE return",
            "url": "https://www.cnn.com/2023/09/18/entertainment/dwayne-johnson-wwe/index.html",
            "time_published": "20230918T172700",
            "authors": [
                "Marianne Garvey"
            ],
            "summary": "Dwayne \"The Rock\" Johnson made a surprise return to the WWE. The WWE's official account on X ( formerly known as Twitter ) , showed a clip of Johnson facing off with John Cena during the WWE SmackDown! Friday night at Ball Arena in Denver.",
            "banner_image": "https://i.ytimg.com/vi/o7D02IdNuL8/hqdefault.jpg",
            "source": "CNN",
            "category_within_source": "Markets",
            "source_domain": "www.cnn.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.217263,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.469476",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Dwayne 'The Rock' Johnson makes WWE return",
            "url": "https://edition.cnn.com/2023/09/18/entertainment/dwayne-johnson-wwe/index.html",
            "time_published": "20230918T172700",
            "authors": [
                "Marianne Garvey"
            ],
            "summary": "Dwayne \"The Rock\" Johnson made a surprise return to the WWE. The WWE's official account on X ( formerly known as Twitter ) , showed a clip of Johnson facing off with John Cena during the WWE SmackDown! Friday night at Ball Arena in Denver.",
            "banner_image": "https://i.ytimg.com/vi/o7D02IdNuL8/hqdefault.jpg",
            "source": "CNN",
            "category_within_source": "Markets",
            "source_domain": "edition.cnn.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.217263,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.469476",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "JNJ: 3 Healthcare Stocks to Buy Today",
            "url": "https://stocknews.com/news/jnj-abbv-amgn-3-healthcare-stocks-to-buy-today/",
            "time_published": "20230918T161805",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "Johnson & Johnson ( JNJ ) , Amgen ( AMGN ) and AbbVie ( ABBV ) are healthcare sector leaders with their company specific transformative catalysts in the fray. All three stocks are rated a strong buy by the propriety POWR Rating, ranking above the 95th percentile.",
            "banner_image": "https://stocknews.com/wp-content/uploads/2022/07/shutterstock_1006149949-scaled.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.204143,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.075161",
                    "ticker_sentiment_score": "-0.031981",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.258743",
                    "ticker_sentiment_score": "0.158904",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.328819",
                    "ticker_sentiment_score": "0.221508",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HZNP",
                    "relevance_score": "0.075161",
                    "ticker_sentiment_score": "0.054204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.396147",
                    "ticker_sentiment_score": "0.21806",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Personal Hygiene Market Size is projected to reach USD 720 Billion by 2030, growing at a CAGR of 3.6%: Straits Research",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34696357/personal-hygiene-market-size-is-projected-to-reach-usd-720-billion-by-2030-growing-at-a-cagr-of-3-",
            "time_published": "20230918T154000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, United States, Sept. 18, 2023 ( GLOBE NEWSWIRE ) -- Personal hygiene is maintaining one's health and hygiene to prevent infectious diseases, fungi, and other illnesses. Regular hand washing, bathing, brushing your teeth after each meal, trimming and cleaning your nails, and other ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.246667,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CL",
                    "relevance_score": "0.027164",
                    "ticker_sentiment_score": "-0.090929",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMB",
                    "relevance_score": "0.027164",
                    "ticker_sentiment_score": "-0.090929",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.027164",
                    "ticker_sentiment_score": "-0.090929",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RBGPF",
                    "relevance_score": "0.027164",
                    "ticker_sentiment_score": "-0.090929",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.135195",
                    "ticker_sentiment_score": "0.109521",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cold Chain Packaging Market Size is projected to reach USD 55.97 Billion by 2030, growing at a CAGR of 10.70%: Straits Research",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34694957/cold-chain-packaging-market-size-is-projected-to-reach-usd-55-97-billion-by-2030-growing-at-a-cagr",
            "time_published": "20230918T151000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, United States, Sept. 18, 2023 ( GLOBE NEWSWIRE ) -- The shipment and packaging of products that need to be kept at a specific temperature to operate correctly are known as \"cold chain packing.\" Cold chain packaging solutions are necessary for the growth of the worldwide market for ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.031253,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.032078",
                    "ticker_sentiment_score": "-0.066034",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley",
            "url": "https://www.zacks.com/stock/news/2151790/the-zacks-analyst-blog-highlights-meta-platforms-walmart-johnson-johnson-pfizer-and-morgan-stanley",
            "time_published": "20230918T120300",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley are part of the Zacks top Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0d/436.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.270413,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.357636",
                    "ticker_sentiment_score": "0.171193",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.147366",
                    "ticker_sentiment_score": "0.039994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.147366",
                    "ticker_sentiment_score": "0.039994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.289748",
                    "ticker_sentiment_score": "0.153621",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.357636",
                    "ticker_sentiment_score": "0.266273",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?",
            "url": "https://www.zacks.com/stock/news/2151652/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv",
            "time_published": "20230918T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default109.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.258161,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.12645",
                    "ticker_sentiment_score": "0.063548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.063425",
                    "ticker_sentiment_score": "0.127352",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.063425",
                    "ticker_sentiment_score": "0.089045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.12645",
                    "ticker_sentiment_score": "0.063548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.12645",
                    "ticker_sentiment_score": "0.063548",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Franklin U.S. Low Volatility High Dividend Index ETF  ( LVHD )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2151659/is-franklin-us-low-volatility-high-dividend-index-etf-lvhd-a-strong-etf-right-now",
            "time_published": "20230918T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default43.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999998"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.207472,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.059598",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.059598",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.059598",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html",
            "time_published": "20230918T091500",
            "authors": [],
            "summary": "Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.019617,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MGNX",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLDX",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PBYI",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.08609",
                    "ticker_sentiment_score": "-0.093515",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/large-molecule-injectable-drugs-market-to-grow-by-usd-191-45-billion-from-2022-2027--north-america-to-account-for-45-of-market-growth---technavio-301929312.html",
            "time_published": "20230918T083500",
            "authors": [],
            "summary": "Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.157274,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAK",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Myopia and presbyopia treatment market to grow by USD 7.94 billion from 2022 to 2027 | Asia to account for 37% of ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/myopia-and-presbyopia-treatment-market-to-grow-by-usd-7-94-billion-from-2022-to-2027--asia-to-account-for-37-of-market-growth--technavio-301929564.html",
            "time_published": "20230918T041500",
            "authors": [],
            "summary": "Myopia and presbyopia treatment market to grow by USD 7.94 billion from 2022 to 2027 | Asia to account for 37% of ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.234998,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "COO",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MTLZF",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ESLOF",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALC",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TOPCF",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EVO",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.184679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Weight Management Devices Market to grow by USD 4.57 billion between 2022 - 2027 | Growth Driven by Growing ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/weight-management-devices-market-to-grow-by-usd-4-57-billion-between-2022---2027--growth-driven-by-growing-obese-population---technavio-301929563.html",
            "time_published": "20230918T031500",
            "authors": [],
            "summary": "Weight Management Devices Market to grow by USD 4.57 billion between 2022 - 2027 | Growth Driven by Growing ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.210776,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BSX",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NOK",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GRMN",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "RSLS",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CUTR",
                    "relevance_score": "0.047559",
                    "ticker_sentiment_score": "0.159676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income",
            "url": "https://www.fool.com/investing/2023/09/17/3-high-quality-dividend-stocks-yeilding-3-to-buy-f/",
            "time_published": "20230917T150900",
            "authors": [
                "Matthew DiLallo"
            ],
            "summary": "These companies generate durable and growing cash flows.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.380651,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AMT",
                    "relevance_score": "0.297301",
                    "ticker_sentiment_score": "0.446826",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.406901",
                    "ticker_sentiment_score": "0.467814",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BEP",
                    "relevance_score": "0.181137",
                    "ticker_sentiment_score": "0.420901",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.136156",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.121343",
                    "ticker_sentiment_score": "0.089341",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Activist Elliott makes inroads at Catalent to build value. Here's what could happen next",
            "url": "https://www.cnbc.com/2023/09/16/activist-elliott-makes-inroads-at-catalent-to-build-value-heres-what-could-happen-next.html",
            "time_published": "20230916T123555",
            "authors": [
                "Kenneth Squire"
            ],
            "summary": "Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical company.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107301862-1694815579218-gettyimages-1189160521-341186042jpeg.jpeg?v=1694867755&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Investing",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.995077"
                }
            ],
            "overall_sentiment_score": 0.226313,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CTLT",
                    "relevance_score": "0.451494",
                    "ticker_sentiment_score": "0.28207",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.036812",
                    "ticker_sentiment_score": "0.089875",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.036812",
                    "ticker_sentiment_score": "0.089875",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYNH",
                    "relevance_score": "0.073546",
                    "ticker_sentiment_score": "0.182991",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "A top-12% portfolio manager over the last 5 years shares how he finds unloved stocks trading at massive discounts - and 6 of the top opportunities in markets right now",
            "url": "https://www.businessinsider.com/how-to-invest-value-stocks-to-buy-top-fund-manager-2023-9",
            "time_published": "20230916T100000",
            "authors": [
                "James Faris"
            ],
            "summary": "6 Undervalued Investments to Make Right Now: Top-12% Fund Manager - Business Insider ...",
            "banner_image": "https://i.insider.com/65035abb2a72d60019d543d4?width=1200&format=jpeg",
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.businessinsider.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999186"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.221784,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MORN",
                    "relevance_score": "0.033894",
                    "ticker_sentiment_score": "0.200285",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.067727",
                    "ticker_sentiment_score": "0.131897",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AIG",
                    "relevance_score": "0.101439",
                    "ticker_sentiment_score": "0.221997",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.067727",
                    "ticker_sentiment_score": "0.131897",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett poured $3 billion into Dow Chemical during the financial crisis. Here's the story of how he helped the manufacturing titan - and doubled his money.",
            "url": "https://africa.businessinsider.com/markets/warren-buffett-poured-dollar3-billion-into-dow-chemical-during-the-financial-crisis/t5nwqfx",
            "time_published": "20230916T093927",
            "authors": [
                "Theron Mohamed"
            ],
            "summary": "Dow agreed to buy Rohm and Haas for nearly $19 billion including debt in July 2008, and roped in Warren Buffett's Berkshire Hathaway to help with the financing. The acquisition was part of Dow's strategy to shift its focus away from bulk chemicals toward higher-margin, specialty chemicals.",
            "banner_image": "https://ocdn.eu/pulscms-transforms/1/XYuktkuTURBXy9iOGFkZDgxOS0yYjdmLTQyMWEtODgwNC0xNzY2MTEyZDkxZDUuanBlZ5GTBc0DFs0Brg",
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "africa.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997405"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.146351,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.095138",
                    "ticker_sentiment_score": "0.047984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.095138",
                    "ticker_sentiment_score": "0.09814",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.095138",
                    "ticker_sentiment_score": "0.09814",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCO",
                    "relevance_score": "0.095138",
                    "ticker_sentiment_score": "0.09814",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSREF",
                    "relevance_score": "0.095138",
                    "ticker_sentiment_score": "0.100654",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.095138",
                    "ticker_sentiment_score": "0.100654",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.095138",
                    "ticker_sentiment_score": "0.100654",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett poured $3 billion into Dow Chemical during the financial crisis. Here's the story of how he helped the manufacturing titan - and doubled his money.",
            "url": "https://markets.businessinsider.com/news/stocks/warren-buffett-berkshire-hathaway-dow-chemical-stock-deal-financial-crisis-2023-9",
            "time_published": "20230916T093900",
            "authors": [
                "Theron Mohamed"
            ],
            "summary": "How Warren Buffett Bet $3 Billion on Dow Chemical, Doubled His Money - Markets Insider ...",
            "banner_image": "https://i.insider.com/59108c04dd089544778b4ca1?width=1200&format=jpeg",
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999995"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.154299,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.044898",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.091826",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.091826",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCO",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.091826",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSREF",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.094628",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.094628",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.049322",
                    "ticker_sentiment_score": "0.094628",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why the F.D.A. Took So Long to Tackle a Disputed Cold Remedy",
            "url": "https://www.nytimes.com/2023/09/15/health/fda-cold-medicine-decongestant.html",
            "time_published": "20230915T202429",
            "authors": [
                "Christina Jewett"
            ],
            "summary": "Pharmacists affiliated with the University of Florida have spent decades nudging the agency to pull a decongestant from over-the-counter medicines.",
            "banner_image": "https://static01.nyt.com/images/2023/09/15/multimedia/15FDA-COLDMEDS-01-pcqm/15FDA-COLDMEDS-01-pcqm-articleLarge.jpg?quality=75&auto=webp&disable=upscale",
            "source": "New York Times",
            "category_within_source": "Business",
            "source_domain": "www.nytimes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.088243,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.024775",
                    "ticker_sentiment_score": "-0.020373",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.024775",
                    "ticker_sentiment_score": "-0.020373",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top Analyst Reports for Meta Platforms, Walmart & Johnson & Johnson",
            "url": "https://www.zacks.com/research-daily/2149578/top-analyst-reports-for-meta-platforms-walmart-johnson-johnson",
            "time_published": "20230915T165900",
            "authors": [
                "Sheraz Mian"
            ],
            "summary": "Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Walmart Inc. (WMT) and Johnson & Johnson (JNJ).",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default157.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.337056,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.206685",
                    "ticker_sentiment_score": "0.333836",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.252141",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.206685",
                    "ticker_sentiment_score": "0.437978",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Jets owner Woody Johnson is privately lobbying GOP megadonors to donate to Trump's campaign",
            "url": "https://www.cnbc.com/2023/09/15/jets-owner-woody-johnson-helps-trump-2024-campaign.html",
            "time_published": "20230915T164546",
            "authors": [
                "Brian Schwartz"
            ],
            "summary": "New York Jets owner Woody Johnson is privately lobbying fellow Republican megadonors to donate to Donald Trump, making him a rare figure in the GOP.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107301011-1694713308286-gettyimages-997467392-AFP_17K1PR.jpeg?v=1694796346&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.270607,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "WBD",
                    "relevance_score": "0.043499",
                    "ticker_sentiment_score": "0.070351",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.043499",
                    "ticker_sentiment_score": "-0.131568",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043499",
                    "ticker_sentiment_score": "0.278581",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The Orthopedic Devices Market Is Expected To Grow At A CAGR Of 5% With Rising Geriatric Population As Per The Business Research Company's Orthopedic Devices Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34619983/the-orthopedic-devices-market-is-expected-to-grow-at-a-cagr-of-5-with-rising-geriatric-population-",
            "time_published": "20230915T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Sept. 15, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's Orthopedic Devices Global Market Report 2023, the global orthopedic devices market has demonstrated remarkable growth, increasing from $43 billion in 2022 to $45.79 billion in 2023, reflecting a robust compound annual ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.258326,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "-0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "-0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMED",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "-0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.106778",
                    "ticker_sentiment_score": "0.078419",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "-0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NUVA",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "-0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "-0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "-0.013",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ: Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?",
            "url": "https://stocknews.com/news/jnj-calt-acb-kvue-which-of-these-3-pharma-stocks-should-you-buy-hold/",
            "time_published": "20230915T140523",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "The pharmaceutical sector is popular amongst investors because of its ability to maintain profit margins irrespective of the economic climate. Moreover, the industry is well-positioned for growth thanks to the growing incidence of chronic diseases and the development of drugs for treating rare ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2023/01/ISt_Biotechnology.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999606"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.980922"
                }
            ],
            "overall_sentiment_score": 0.130774,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ACB",
                    "relevance_score": "0.180325",
                    "ticker_sentiment_score": "0.233279",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CALT",
                    "relevance_score": "0.108794",
                    "ticker_sentiment_score": "0.16731",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.318439",
                    "ticker_sentiment_score": "0.230508",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Instacart Raises IPO Price Nearly 10% After Arm's Splashy Start",
            "url": "https://www.forbes.com/sites/dereksaul/2023/09/15/instacart-raises-ipo-price-nearly-10-after-arms-splashy-start/",
            "time_published": "20230915T133057",
            "authors": [
                "Derek Saul"
            ],
            "summary": "Instacart will begin trading Tuesday at a projected valuation between $9.3 billion to $9.9 billion.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65045b81c158d168d252cccb/0x0.jpg?format=jpg&crop=2813,1582,x0,y293,safe&width=1200",
            "source": "Forbes",
            "category_within_source": "Business",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.2051,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Great Dividend Stocks You Can Buy for Less Than $50",
            "url": "https://www.fool.com/investing/2023/09/15/3-great-dividend-stocks-you-can-buy-for-less-than/",
            "time_published": "20230915T121000",
            "authors": [
                "Josh Kohn-Lindquist"
            ],
            "summary": "These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50.",
            "banner_image": "https://media.ycharts.com/charts/50b5a75cce3a9b4a6743f748d1cc9347.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.576289"
                }
            ],
            "overall_sentiment_score": 0.247036,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AAP",
                    "relevance_score": "0.039289",
                    "ticker_sentiment_score": "0.083081",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.306484",
                    "ticker_sentiment_score": "0.062256",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROL",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.135234",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.078482",
                    "ticker_sentiment_score": "0.005112",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KR",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.28172",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.039289",
                    "ticker_sentiment_score": "-0.001967",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should iShares Russell Top 200 Value ETF  ( IWX )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2149290/should-ishares-russell-top-200-value-etf-iwx-be-on-your-investing-radar",
            "time_published": "20230915T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default16.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.287419,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.114026",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.123209",
                    "ticker_sentiment_score": "-0.022289",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "-0.019043",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.123209",
                    "ticker_sentiment_score": "-0.022289",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Arm debut will help jump-start IPO market, early Airbnb investor Rick Heitzmann suggests",
            "url": "https://www.cnbc.com/2023/09/14/arm-ipo-to-help-jump-start-ipo-market-airbnb-investor-rick-heitzmann.html",
            "time_published": "20230914T232845",
            "authors": [
                "Stephanie Landsman"
            ],
            "summary": "\"People are looking for the new toy,\" FirstMark Capital's Rick Heitzmann says after Arm Holdings stock jumps 25% in its first trading day.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107301189-16947281331694728129-31198210439-1080pnbcnews.jpg?v=1694728483&w=750&h=422&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Finance",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.123806,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.106541",
                    "ticker_sentiment_score": "0.037761",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABNB",
                    "relevance_score": "0.106541",
                    "ticker_sentiment_score": "0.156363",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PINS",
                    "relevance_score": "0.106541",
                    "ticker_sentiment_score": "0.156363",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.106541",
                    "ticker_sentiment_score": "0.037761",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SFTBF",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "0.03214",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson ditching script logo after 130 years",
            "url": "https://www.foxbusiness.com/markets/johnson-johnson-ditching-script-logo-after-130-years",
            "time_published": "20230914T201257",
            "authors": [
                "Eric Revell"
            ],
            "summary": "on Thursday announced that the company is updating its logo as part of a brand realignment that will unite its medical technology and pharmaceutical segments under its brand name.",
            "banner_image": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/531dcee8-89de-4810-8e02-e3968e574ab5/0e51d223-4d52-45ff-b003-007c759c07fb/1280x720/match/image.jpg",
            "source": "Fox Business News",
            "category_within_source": "n/a",
            "source_domain": "www.foxbusiness.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.268007,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.459624",
                    "ticker_sentiment_score": "0.474228",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations - Johnson & Johnson  ( NYSE:JNJ ) , Procter & Gamble  ( NYSE:PG ) ",
            "url": "https://www.benzinga.com/news/large-cap/23/09/34589803/lawsuit-against-dummy-pills-for-allergy-cold-johnson-johnson-and-procter-gamble-face-allegations",
            "time_published": "20230914T191007",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "In a recent lawsuit, Johnson & Johnson JNJ and Procter & Gamble Co PG are facing allegations of misleading consumers regarding decongestant cold medicines containing an ingredient that a unanimous FDA advisory panel declared ineffective this week.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/14/pill-_image_by_arek_socha_from_pixabay_.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.175523,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.388879",
                    "ticker_sentiment_score": "-0.24671",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.388879",
                    "ticker_sentiment_score": "-0.24671",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson is replacing its iconic logo | Business",
            "url": "https://www.cnn.com/2023/09/14/business/johnson-and-johnson-new-logo/index.html",
            "time_published": "20230914T184200",
            "authors": [
                "Jordan Valinsky"
            ],
            "summary": "Johnson & Johnson is replacing its iconic logo ...",
            "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/230914132720-01-new-johnson-and-johnson-logo.jpg?c=16x9&q=w_800,c_fill",
            "source": "CNN",
            "category_within_source": "Markets",
            "source_domain": "www.cnn.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.117903,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.421485",
                    "ticker_sentiment_score": "0.128315",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.288893",
                    "ticker_sentiment_score": "0.076011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "0.100178",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "0.100178",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Notification of managers' transactions",
            "url": "https://www.globenewswire.com/news-release/2023/09/14/2743487/0/en/Notification-of-managers-transactions.html",
            "time_published": "20230914T152000",
            "authors": [
                "Chemometec A/S"
            ],
            "summary": "ANNOUNCEMENT NO. ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.119699,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.124107",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.124107",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.124107",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "IoT Medical Devices Market Size is projected to reach USD 112 billion by 2031, growing at a CAGR of 27.6%: Straits Research",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34583244/iot-medical-devices-market-size-is-projected-to-reach-usd-112-billion-by-2031-growing-at-a-cagr-of",
            "time_published": "20230914T141500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, United States, Sept. 14, 2023 ( GLOBE NEWSWIRE ) -- IoT medical devices manage mechanical ventilation systems and artificial airways, disperse aerosol-based medications, and identify and treat cardiopulmonary diseases.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.191031,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DGWPF",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.025173",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GTLS",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.025173",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.025173",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RMD",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.044883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MASI",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.025173",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.025173",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WLDS",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.089755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.089755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMIN",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.140861",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson is getting rid of its script logo after more than 130 years",
            "url": "https://apnews.com/article/johnson-logo-change-cursive-7236463751d2ba89a7a8858c3accf162",
            "time_published": "20230914T140317",
            "authors": [
                "TOM MURPHY"
            ],
            "summary": "Johnson & Johnson is signing off on a new logo. The health care giant said Thursday that it will replace the well-known signature script it has used since 1887 with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices.",
            "banner_image": "https://dims.apnews.com/dims4/default/152aa8d/2147483647/strip/true/crop/2709x1524+0+141/resize/1440x810!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F36%2Fd6%2Fccb01e9611506fe650df27cb9feb%2Fa3ec899b17754bfeaca17df501584e06",
            "source": "Associated Press",
            "category_within_source": "Business",
            "source_domain": "apnews.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.170367,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.063091",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HHC",
                    "relevance_score": "0.095899",
                    "ticker_sentiment_score": "0.176122",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.453099",
                    "ticker_sentiment_score": "0.233741",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Percutaneous Coronary Intervention Guidance Devices Market Revenue to Cross USD 23.5 billion by 2031, Expanding at a 6.1% CAGR: TMR Report",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34578437/percutaneous-coronary-intervention-guidance-devices-market-revenue-to-cross-usd-23-5-billion-by-20",
            "time_published": "20230914T123000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Sept. 14, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The percutaneous coronary intervention guidance devices market was estimated to have acquired US$ 12.2 billion in 2021.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.291306,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BSX",
                    "relevance_score": "0.04076",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04076",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Arm Holdings IPO shares expected to begin trading today: Check stock price, valuation, ticker symbol",
            "url": "https://www.financialexpress.com/business/investing-abroad-arm-holdings-ipo-shares-expected-to-begin-trading-today-check-stock-price-valuation-ticker-symbol-3243273/",
            "time_published": "20230914T103700",
            "authors": [
                "Bloomberg"
            ],
            "summary": "The chip designer, which is owned by SoftBank Group Corp., sold 95.5 million American depositary shares for $51 apiece, according to a statement Wednesday confirming an earlier Bloomberg News report. Arm had marketed the shares for $47 to $51 each.",
            "banner_image": "https://www.financialexpress.com/wp-content/uploads/2023/09/15-2.jpg",
            "source": "The Financial Express",
            "category_within_source": "n/a",
            "source_domain": "www.financialexpress.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.972193"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.118057,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.03621",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.090304",
                    "ticker_sentiment_score": "0.038265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.179454",
                    "ticker_sentiment_score": "0.065756",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.152061",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "-0.095404",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RIVN",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.03621",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LDNXF",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.152061",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MFG",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.152061",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSM",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.152061",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SFTBF",
                    "relevance_score": "0.349945",
                    "ticker_sentiment_score": "0.158484",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "-0.095404",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Warren Buffett Stocks That Are Near Their 52-Week Lows",
            "url": "https://www.fool.com/investing/2023/09/14/warren-buffett-stocks-near-their-52-week-low/",
            "time_published": "20230914T092000",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Should you consider loading up on these stocks?",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.933642"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.13034,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.042346",
                    "ticker_sentiment_score": "0.223952",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.084572",
                    "ticker_sentiment_score": "0.107844",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.404563",
                    "ticker_sentiment_score": "0.028488",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PARA",
                    "relevance_score": "0.168197",
                    "ticker_sentiment_score": "0.011532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.042346",
                    "ticker_sentiment_score": "0.271074",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.249958",
                    "ticker_sentiment_score": "0.13399",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Innovations and Opportunities in European Healthcare Technologies",
            "url": "https://investingnews.com/innovations-and-opportunities-in-european-healthcare-technologies/",
            "time_published": "20230914T041926",
            "authors": [
                "Investing News Network"
            ],
            "summary": "These advanced European technologies are often only distributed and implemented exclusively within the European Union. The good news is that it doesn't need to stay this way.",
            "banner_image": "https://investingnews.com/media-library/doctor-with-hands-together-palms-up-below-digital-medical-symbols.png?id=39072252&width=1200&height=800&quality=85&coordinates=0%2C0%2C0%2C0",
            "source": "Investing News Network",
            "category_within_source": "n/a",
            "source_domain": "investingnews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.989041"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.349194,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CABGY",
                    "relevance_score": "0.021718",
                    "ticker_sentiment_score": "0.178326",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NOK",
                    "relevance_score": "0.021718",
                    "ticker_sentiment_score": "0.178326",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.021718",
                    "ticker_sentiment_score": "0.131751",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.021718",
                    "ticker_sentiment_score": "0.178326",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.021718",
                    "ticker_sentiment_score": "0.131751",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.021718",
                    "ticker_sentiment_score": "0.131751",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SoftBank-backed Arm raises $4.87 billion in biggest IPO of the year",
            "url": "https://www.business-standard.com/world-news/softbank-backed-arm-raises-4-87-billion-in-biggest-ipo-of-the-year-123091400129_1.html",
            "time_published": "20230914T030538",
            "authors": [
                "Bloomberg"
            ],
            "summary": "By Gillian Tan, Ian King, Ryan Gould and Amy Or Arm Holdings Plc priced its initial public offering at the top end of its range to raise $4.87 billion in the largest listing of the year, one that could give a major lift to long-suffering equity markets.",
            "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-09/14/full/1694660662-3821.jpg?im=FeatureCrop,size=(826,465)",
            "source": "Business Standard",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.business-standard.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.983605"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.938793"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.117899,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.035942",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "0.037882",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.169676",
                    "ticker_sentiment_score": "0.063204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.151261",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "-0.094807",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RIVN",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.035942",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LDNXF",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.151261",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MFG",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.151261",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSM",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.151261",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SFTBF",
                    "relevance_score": "0.331765",
                    "ticker_sentiment_score": "0.152207",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.042723",
                    "ticker_sentiment_score": "-0.094807",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Outpaces Stock Market Gains: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2148591/johnson-johnson-jnj-outpaces-stock-market-gains-what-you-should-know",
            "time_published": "20230913T214517",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "In the latest trading session, Johnson & Johnson (JNJ) closed at $163.99, marking a +0.25% move from the previous day.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default195.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.147544,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.5633",
                    "ticker_sentiment_score": "0.193809",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Kimberly-Clark Elects Deeptha Khanna to its Board of Directors",
            "url": "https://www.prnewswire.com/news-releases/kimberly-clark-elects-deeptha-khanna-to-its-board-of-directors-301926867.html",
            "time_published": "20230913T201900",
            "authors": [
                "Kimberly-Clark Corporation"
            ],
            "summary": "DALLAS, Sept. 13, 2023 /PRNewswire/ -- Kimberly-Clark Corporation ( NYSE: KMB ) today announced that Deeptha Khanna has been elected to its board of directors effective immediately.",
            "banner_image": "https://mma.prnewswire.com/media/648588/Kimberly_Clark_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.43622,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KMB",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.665917",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.214937",
                    "ticker_sentiment_score": "0.076385",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.108466",
                    "ticker_sentiment_score": "0.050212",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Buy Birkenstock? What to know about Crocs, Allbirds and the uneven history of the footwear IPO market",
            "url": "https://www.cnbc.com/2023/09/13/buy-birkenstock-ipo-crocs-allbirds-and-an-uneven-footwear-market.html",
            "time_published": "20230913T185139",
            "authors": [
                "Natalie Rose Goldberg"
            ],
            "summary": "Iconic footwear brand Birkenstock is planning to go public at a time when tech IPOs including Arm and Instacart are hoping to give the IPO market a jolt.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106355947-1580060045659distruptor_80px.jpg?v=1580163340&h=80",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999612"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.918141"
                }
            ],
            "overall_sentiment_score": 0.121346,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "-0.076833",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DECK",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.070338",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "0.032926",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CROX",
                    "relevance_score": "0.063313",
                    "ticker_sentiment_score": "0.120411",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "-0.005732",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.042234",
                    "ticker_sentiment_score": "-0.00198",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.021124",
                    "ticker_sentiment_score": "-0.005732",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Annual Report 2022/23 - Continued solid earnings, but weaker growth amid challenging market conditions",
            "url": "https://www.globenewswire.com/news-release/2023/09/13/2742833/0/en/Annual-Report-2022-23-Continued-solid-earnings-but-weaker-growth-amid-challenging-market-conditions.html",
            "time_published": "20230913T175000",
            "authors": [
                "Chemometec A/S"
            ],
            "summary": "ANNOUNCEMENT NO. ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.233703,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.065685",
                    "ticker_sentiment_score": "0.061067",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.065685",
                    "ticker_sentiment_score": "0.061067",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.065685",
                    "ticker_sentiment_score": "0.061067",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Guidance for the 2023/24 financial year",
            "url": "https://www.globenewswire.com/news-release/2023/09/13/2742832/0/en/Guidance-for-the-2023-24-financial-year.html",
            "time_published": "20230913T174500",
            "authors": [
                "Chemometec A/S"
            ],
            "summary": "ANNOUNCEMENT NO. ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.140299,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.299478",
                    "ticker_sentiment_score": "0.130157",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.299478",
                    "ticker_sentiment_score": "0.130157",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.299478",
                    "ticker_sentiment_score": "0.130157",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The latest Covid-19 vaccine is here. Here's where and when to get it - and RSV and flu shots, too",
            "url": "https://www.cnn.com/2023/09/13/health/updated-covid-vaccine-where-when-flu-rsv-wellness/index.html",
            "time_published": "20230913T163800",
            "authors": [
                "Amanda Musa"
            ],
            "summary": "Now that the US Food and Drug Administration and Centers for Disease Control and Prevention have signed off, you won't have to wait long to get your updated Covid-19 shot. Major pharmacy chains have already started rolling out vaccine appointments.",
            "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/230831162545-04-cnn-news-quiz-083123.jpg?c=16x9&q=h_144,w_256,c_fill",
            "source": "CNN",
            "category_within_source": "Markets",
            "source_domain": "www.cnn.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": -0.007209,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.161349",
                    "ticker_sentiment_score": "0.058147",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RAD",
                    "relevance_score": "0.027072",
                    "ticker_sentiment_score": "0.048086",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.027072",
                    "ticker_sentiment_score": "0.075894",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBD",
                    "relevance_score": "0.054114",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.054114",
                    "ticker_sentiment_score": "0.085893",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.054114",
                    "ticker_sentiment_score": "0.085893",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.027072",
                    "ticker_sentiment_score": "0.183956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Internal Hiring Boosts Retention and Saves Money, Yet Has Slumped Post Pandemic, The Josh Bersin Company Finds",
            "url": "https://www.prnewswire.com/news-releases/internal-hiring-boosts-retention-and-saves-money-yet-has-slumped-post-pandemic-the-josh-bersin-company-finds-301926233.html",
            "time_published": "20230913T130000",
            "authors": [
                "The Josh Bersin Company"
            ],
            "summary": "• Internal mobility initiatives and hiring processes rose in popularity during the pandemic to become a source of innovation, employee retention, a core driver of company culture, and broad savings • But the focus on internal recruitment has waned-slumping to represent just 24% of all hires from ...",
            "banner_image": "https://mma.prnewswire.com/media/1670975/The_Josh_Bersin_Company.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.360481,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.032035",
                    "ticker_sentiment_score": "0.076029",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "How We'll Tap This Spinoff For 200%+ Dividend Growth",
            "url": "https://www.forbes.com/sites/brettowens/2023/09/13/how-well-tap-this-spinoff-for-200-dividend-growth/",
            "time_published": "20230913T122100",
            "authors": [
                "Brett Owens"
            ],
            "summary": "Let's dive into this Johnson & Johnson (JNJ) spinoff-because it shows exactly how we can tap \"splits\" like these to grab not one but TWO income streams.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64fb161119c88be1f31a562f/0x0.jpg?format=jpg&width=1200",
            "source": "Forbes",
            "category_within_source": "Markets",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.977154"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.318664,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.227716",
                    "ticker_sentiment_score": "0.297337",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CNXC",
                    "relevance_score": "0.115048",
                    "ticker_sentiment_score": "0.138303",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.227716",
                    "ticker_sentiment_score": "0.193184",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.264351",
                    "ticker_sentiment_score": "0.426032",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Here's My Top Growth Stock to Buy in 2023",
            "url": "https://www.fool.com/investing/2023/09/13/heres-my-top-growth-stock-to-buy-in-2023/",
            "time_published": "20230913T114100",
            "authors": [
                "Anders Bylund"
            ],
            "summary": "The growth train is leaving the station and you don't want to miss it. Find out why this stock remains a strong buy even after doubling in 2023.",
            "banner_image": "https://media.ycharts.com/charts/b825d8f97e5bb8e0ef7fac8c76fc4fcf.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.302354,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ROKU",
                    "relevance_score": "0.650245",
                    "ticker_sentiment_score": "0.469434",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MO",
                    "relevance_score": "0.184834",
                    "ticker_sentiment_score": "0.218184",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.123844",
                    "ticker_sentiment_score": "0.171986",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Better Buy: J&J vs. Kenvue",
            "url": "https://www.fool.com/investing/2023/09/13/better-buy-jj-vs-kenvue/",
            "time_published": "20230913T093000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "You can count on both of these companies for passive income, too.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.352206,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.545806",
                    "ticker_sentiment_score": "0.499731",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.148426",
                    "ticker_sentiment_score": "0.170505",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34502706/johnson-johnson-unusual-options-activity",
            "time_published": "20230912T191545",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.161929,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MS",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.75957",
                    "ticker_sentiment_score": "0.283185",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Your cold pills could be yanked off the shelf. An FDA panel just ruled some of them don't work.",
            "url": "https://www.businessinsider.com/cold-medicine-fda-phenylephrine-congestion-does-not-work-2023-9",
            "time_published": "20230912T173900",
            "authors": [
                "Associated Press",
                "Haley Tenore"
            ],
            "summary": "Your cold medicine may soon be pulled from shelves - Business Insider ...",
            "banner_image": "https://i.insider.com/65008d62d978e50019193bf7?width=1200&format=jpeg",
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.014504,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.052918",
                    "ticker_sentiment_score": "0.035795",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Decongestant found in many cold, allergy medicines doesn't actually work, FDA advisors say",
            "url": "https://www.cnbc.com/2023/09/12/decongestant-phenylephrine-ineffective.html",
            "time_published": "20230912T164833",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "In a unanimous vote, advisors said oral versions of phenylephrine - a nasal decongestant found in versions of drugs like Nyquil and Benadryl - isn't effective.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107299276-1694535874402-gettyimages-1158660407-341550634_1-9.jpeg?v=1694537313&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.138866,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.107978",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.107978",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.107978",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NVS: 3 Pharma Stocks Surpassing Johnson & Johnson  ( JNJ ) ",
            "url": "https://stocknews.com/news/nvs-hznp-rdy-jnj-amgn-3-pharma-stocks-surpassing-johnson-johnson-jnj/",
            "time_published": "20230912T163807",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "NVS: 3 Pharma Stocks Surpassing Johnson & Johnson ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2022/03/shutterstock_745024336-scaled.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.623304"
                }
            ],
            "overall_sentiment_score": 0.23135,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVS",
                    "relevance_score": "0.393241",
                    "ticker_sentiment_score": "0.301748",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.087824",
                    "ticker_sentiment_score": "0.171752",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HZNP",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.124567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.058615",
                    "ticker_sentiment_score": "0.11319",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KDNY",
                    "relevance_score": "0.029327",
                    "ticker_sentiment_score": "0.198322",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "AstraZeneca  ( AZN )  Posts Upbeat Data on Lung Cancer Drug Combo",
            "url": "https://www.zacks.com/stock/news/2147960/astrazeneca-azn-posts-upbeat-data-on-lung-cancer-drug-combo",
            "time_published": "20230912T154900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Data from a late-stage study shows that AstraZeneca's (AZN) Tagrisso combined with chemotherapy cut the risk of disease progression or death by 38% in certain lung cancer patients.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e5/1416.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.128415,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ANVS",
                    "relevance_score": "0.249744",
                    "ticker_sentiment_score": "0.072946",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.573826",
                    "ticker_sentiment_score": "0.183949",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.12645",
                    "ticker_sentiment_score": "-0.05543",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Popular nasal decongestant doesn't actually relieve congestion, FDA advisers say",
            "url": "https://apnews.com/article/sudafed-decongestants-phenylephrine-pseudoephedrine-fda-0f140bafae9a500c5fba05fe764ecb66",
            "time_published": "20230912T151400",
            "authors": [
                "MATTHEW PERRONE"
            ],
            "summary": "Popular nasal decongestant doesn't actually relieve congestion, FDA experts say The Associated Press ...",
            "banner_image": "https://dims.apnews.com/dims4/default/ab7f939/2147483647/strip/true/crop/2000x1332+0+51/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fe2%2F30%2Fc1723158a0b51595916e14e6c827%2F92aa77f7ddc54bc883f72e2ae37e1aad",
            "source": "Associated Press",
            "category_within_source": "Markets",
            "source_domain": "apnews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.038656,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HHC",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "0.164222",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "-0.025989",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2147555/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar",
            "time_published": "20230912T102007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default149.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.238148,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JPM",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.069101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.069101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.069101",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J  ( JNJ )  Seeks Approval for Bladder Cancer Drug in Europe",
            "url": "https://www.zacks.com/stock/news/2147378/jj-jnj-seeks-approval-for-bladder-cancer-drug-in-europe",
            "time_published": "20230911T163100",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J's (JNJ) erdafitinib is already marketed as Balversa in the United States for FGFR-altered metastatic UC. Balversa is approved by the FDA under the accelerated pathway.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.983605"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.132898,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CORT",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.067355",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVAX",
                    "relevance_score": "0.344712",
                    "ticker_sentiment_score": "0.144386",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EXEL",
                    "relevance_score": "0.344712",
                    "ticker_sentiment_score": "0.297581",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "-0.054565",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Prostate Cancer Drugs Market Is Expected To Reach A Value Of $23 Billion By 2027 At A CAGR Of More Than 5 % As Per The Business Research Company's Prostate Cancer Drugs Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34446203/the-prostate-cancer-drugs-market-is-expected-to-reach-a-value-of-23-billion-by-2027-at-a-cagr-of-m",
            "time_published": "20230911T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Sept. 11, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Prostate Cancer Drugs Global Market Report 2023, the global prostate cancer drugs market is making strides worth noting.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": -0.098411,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.059341",
                    "ticker_sentiment_score": "0.012045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.059341",
                    "ticker_sentiment_score": "0.012045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.059341",
                    "ticker_sentiment_score": "0.012045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.059341",
                    "ticker_sentiment_score": "0.012045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.059341",
                    "ticker_sentiment_score": "0.012045",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Stock Market Fades; Twinkie Maker Rallies On Deal News",
            "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-fased-from-strong-start-twinkie-maker-rallies-on-deal-news/",
            "time_published": "20230911T144900",
            "authors": [
                "KIMBERLEY KOENIG",
                "Investor's Business Daily"
            ],
            "summary": "Stock Market Fades. Twinkie Maker Rallies On Deal News Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/10/SNAPPER_twinkies_100722_shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.109656,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "-0.062694",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TENB",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.015332",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRNX",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.111231",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.013041",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.014049",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.311676",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TWNK",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.089065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.148053",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EADSF",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.18343",
                    "ticker_sentiment_score": "0.013522",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RTX",
                    "relevance_score": "0.18343",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.18343",
                    "ticker_sentiment_score": "0.387734",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LPLA",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.184778",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's an easy way to make a more concentrated play on the 'Magnificent Seven' stocks",
            "url": "https://www.marketwatch.com/story/heres-an-easy-way-to-make-a-more-concentrated-play-on-the-magnificent-seven-stocks-b4fd8c1e",
            "time_published": "20230911T143200",
            "authors": [
                "Philip van Doorn"
            ],
            "summary": "The S&P 500 is highly concentrated on the largest tech stocks. But there are other broad indexes with even heavier concentration to tech giants.",
            "banner_image": "https://images.mktw.net/im-849810?width=700&height=607",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.947132"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.226582,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.109152",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.109152",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.109152",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.109152",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.109152",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.109152",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.098862",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.147818",
                    "ticker_sentiment_score": "0.181484",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here are the 16 stocks Jim Cramer is watching, including Twinkie deal, auto strike risk",
            "url": "https://www.cnbc.com/2023/09/11/here-are-the-16-stocks-jim-cramer-is-watching-including-twinkie-deal-auto-strike-risk.html",
            "time_published": "20230911T134551",
            "authors": [
                "Jim Cramer"
            ],
            "summary": "Here are some of the tickers on my radar for Monday, Sept. 11, taken directly from my reporter's notebook.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107298353-1694435863289-gettyimages-173506322-75531150.jpeg?v=1694439951&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.132592,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "EVR",
                    "relevance_score": "0.072876",
                    "ticker_sentiment_score": "0.273011",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BC",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "-0.135271",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "-0.058171",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.072876",
                    "ticker_sentiment_score": "-0.106796",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BF-A",
                    "relevance_score": "0.072876",
                    "ticker_sentiment_score": "0.156313",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "-0.033649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TWNK",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "0.034479",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "0.286515",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BROS",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "-0.148986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DASH",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "0.194618",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GIS",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "0.034479",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.072876",
                    "ticker_sentiment_score": "-0.052953",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.072876",
                    "ticker_sentiment_score": "-0.186229",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TPR",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "-0.238884",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.216215",
                    "ticker_sentiment_score": "-0.044657",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STZ",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "0.193367",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AFRM",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "-0.067375",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SQ",
                    "relevance_score": "0.145145",
                    "ticker_sentiment_score": "0.318769",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis - Novartis  ( NYSE:NVS ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34440622/another-arthritis-blockbuster-drug-faces-generic-competition-novartis-sandoz-inks-pact-with-samsu",
            "time_published": "20230911T133200",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Sandoz, a generic and biosimilar medicines unit of Novartis AG NVS, has entered a development and commercialization agreement with Samsung Bioepis. The agreement provides Sandoz exclusive rights to commercialize the biosimilar SB17 ustekinumab in the US, Canada, EEA, Switzerland, and the U.K.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/11/nvs.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.185087,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.163659",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.244215",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.265849",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.094961",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.371523",
                    "ticker_sentiment_score": "-0.065606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.371523",
                    "ticker_sentiment_score": "-0.101034",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Trending Stock Johnson & Johnson  ( JNJ )  a Buy Now?",
            "url": "https://www.zacks.com/stock/news/2147101/is-trending-stock-johnson-johnson-jnj-a-buy-now",
            "time_published": "20230911T130010",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default201.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                }
            ],
            "overall_sentiment_score": 0.241885,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.481177",
                    "ticker_sentiment_score": "0.16653",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer drug-analysts",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-tagrisso-chemo-combo-results-raise-bar-jj-cancer-drug-analysts-2023-09-11/",
            "time_published": "20230911T121500",
            "authors": [
                "Maggie Fick"
            ],
            "summary": "AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer ...",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/Z7C3LXVLABIWJCVMO4JCQLWQGY.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.081894,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.366061",
                    "ticker_sentiment_score": "-0.013231",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.208424",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.094762",
                    "ticker_sentiment_score": "0.079645",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Treatment with RYBREVANT®  ( amivantamab-vmjw )  and Lazertinib Plus Chemotherapy Showed Durable Progression-Free Survival in Patients with Previously Treated EGFR-Mutated Advanced Non-Small Cell Lung Cancer",
            "url": "https://www.prnewswire.com/news-releases/treatment-with-rybrevant-amivantamab-vmjw-and-lazertinib-plus-chemotherapy-showed-durable-progression-free-survival-in-patients-with-previously-treated-egfr-mutated-advanced-non-small-cell-lung-cancer-301923248.html",
            "time_published": "20230911T113000",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Treatment with RYBREVANT® ( amivantamab-vmjw ) and Lazertinib Plus Chemotherapy Showed Durable Progression ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.019331,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.011768",
                    "ticker_sentiment_score": "-0.026517",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.082231",
                    "ticker_sentiment_score": "-0.003137",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JWCTF",
                    "relevance_score": "0.011768",
                    "ticker_sentiment_score": "0.058098",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Major shareholder announcement - BlackRock, Inc.",
            "url": "https://www.globenewswire.com/news-release/2023/09/11/2740670/0/en/Major-shareholder-announcement-BlackRock-Inc.html",
            "time_published": "20230911T111500",
            "authors": [
                "Chemometec A/S"
            ],
            "summary": "ANNOUNCEMENT NO. ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.142316,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.666827",
                    "ticker_sentiment_score": "0.299741",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.076328",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.076328",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.076328",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Could This Issue Sink Johnson & Johnson's Stock Price?",
            "url": "https://www.fool.com/investing/2023/09/11/could-this-issue-sink-johnson-johnson-stock/",
            "time_published": "20230911T104900",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "Don't be too quick to press the sell button.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": -0.024232,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.059341",
                    "ticker_sentiment_score": "-0.003005",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.059341",
                    "ticker_sentiment_score": "0.164265",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.628304",
                    "ticker_sentiment_score": "-0.047867",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?",
            "url": "https://www.zacks.com/stock/news/2147010/should-you-invest-in-the-vanguard-health-care-etf-vht",
            "time_published": "20230911T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default221.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.2532,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.064794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.125901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.064794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.064794",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Visgenx Presents Poster at the Cell and Gene Therapy: Advancing Next Generation Therapies, West Coast Symposium",
            "url": "https://www.prnewswire.com/news-releases/visgenx-presents-poster-at-the-cell-and-gene-therapy-advancing-next-generation-therapies-west-coast-symposium-301922818.html",
            "time_published": "20230911T100000",
            "authors": [
                "Visgenx"
            ],
            "summary": "Poster presentation covered the Company's platform on synthetic AAV genomes for gene delivery Symposium Program was Presented by Johnson & Johnson and California Life Sciences",
            "banner_image": "https://mma.prnewswire.com/media/2076433/Visgenx_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": -0.002403,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085936",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding.",
            "url": "https://www.fool.com/investing/2023/09/11/warren-buffett-highest-yielding-stock-57-annually/",
            "time_published": "20230911T092100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "Relative to Berkshire's cost basis in the company, this longtime Buffett holding is generating more than 11 times the nominal yield of Citigroup.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747021%2Fbuffett11-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.779048"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.311653,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "C",
                    "relevance_score": "0.238133",
                    "ticker_sentiment_score": "0.262305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.081034",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.276313",
                    "ticker_sentiment_score": "0.263659",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.04028",
                    "ticker_sentiment_score": "0.150347",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.199365",
                    "ticker_sentiment_score": "0.229442",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.160099",
                    "ticker_sentiment_score": "0.094183",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Smart Healthcare Market to grow by USD 115.39 billion from 2022-2027; North America to account for 43% of market ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/smart-healthcare-market-to-grow-by-usd-115-39-billion-from-2022-2027-north-america-to-account-for-43-of-market-growth---technavio-301922137.html",
            "time_published": "20230911T071500",
            "authors": [],
            "summary": "Smart Healthcare Market to grow by USD 115.39 billion from 2022-2027. North America to account for 43% of market ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.346584,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.156123",
                    "ticker_sentiment_score": "-0.055715",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HON",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHG",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPE",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZBRA",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Autoclave Market to grow by USD 571.78 million from 2022 to 2027, North America to account for 34% of market growth ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/autoclave-market-to-grow-by-usd-571-78-million-from-2022-to-2027--north-america-to-account-for-34-of-market-growth--technavio-301921875.html",
            "time_published": "20230911T011500",
            "authors": [],
            "summary": "Autoclave Market to grow by USD 571.78 million from 2022 to 2027, North America to account for 34% of market growth ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.043008,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MTLZF",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STE",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "YMATF",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WM",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "-0.166735",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHCCF",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GNGBY",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip",
            "url": "https://www.fool.com/investing/2023/09/10/bargain-hunting-with-100-this-new-sp-500-dividend/",
            "time_published": "20230910T100000",
            "authors": [
                "Josh Kohn-Lindquist"
            ],
            "summary": "The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.",
            "banner_image": "https://media.ycharts.com/charts/d6c8ca17e45caed3b44bcc4a3d712b76.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.291351,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.525907",
                    "ticker_sentiment_score": "0.358859",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.051886",
                    "ticker_sentiment_score": "-0.002998",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "New to Investing? Here's How You Can Get Started With $500.",
            "url": "https://www.fool.com/investing/2023/09/10/new-to-investing-heres-how-you-can-get-started-wit/",
            "time_published": "20230910T090000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "You don't have to invest a lot to start building a winning portfolio.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999941"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                }
            ],
            "overall_sentiment_score": 0.308697,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.129017",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.129017",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.204993",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.15606",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.15606",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "StockNews.com Downgrades Johnson & Johnson  ( NYSE:JNJ )  to Buy",
            "url": "https://www.defenseworld.net/2023/09/10/stocknews-com-downgrades-johnson-johnson-nysejnj-to-buy.html",
            "time_published": "20230910T061442",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was downgraded by investment analysts at StockNews.com from a \"strong-buy\" rating to a \"buy\" rating in a research note issued on Friday.",
            "banner_image": "https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.274262,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BCS",
                    "relevance_score": "0.042271",
                    "ticker_sentiment_score": "0.025352",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.686097",
                    "ticker_sentiment_score": "0.431784",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Stock Downgraded to \"Buy\" Rating by StockNews.com",
            "url": "https://www.claytoncountyregister.com/news2/johnson-johnson-nysejnj-downgraded-by-stocknews-com/346086/",
            "time_published": "20230909T124029",
            "authors": [
                "Lira Mercer"
            ],
            "summary": "Johnson & Johnson Stock Downgraded to \"Buy\" Rating by ... Clayton County Register ...",
            "banner_image": "https://www.claytoncountyregister.com/wp-content/uploads/2023/07/mfrack_realistic_photo_of_German_stock_exchange_bb944323-bcb0-4296-9fca-b6d34aafb7bd.jpeg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.claytoncountyregister.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.122099,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "C",
                    "relevance_score": "0.107016",
                    "ticker_sentiment_score": "0.009815",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EQH",
                    "relevance_score": "0.107016",
                    "ticker_sentiment_score": "0.124779",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.107016",
                    "ticker_sentiment_score": "0.009815",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.107016",
                    "ticker_sentiment_score": "0.009815",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.653656",
                    "ticker_sentiment_score": "0.1809",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 Pharmaceutical Stocks That Are Too Cheap to Ignore",
            "url": "https://www.fool.com/investing/2023/09/09/pharmaceutical-stocks-that-are-too-cheap-to-ignore/",
            "time_published": "20230909T112000",
            "authors": [
                "Jim Halley"
            ],
            "summary": "Viatris, GSK, and Organon are all trading at less than 7 times earnings.",
            "banner_image": "https://media.ycharts.com/charts/10136ff5365d9298cab1c9f1128d1005.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999981"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.27235,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.049424",
                    "ticker_sentiment_score": "0.082757",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.049424",
                    "ticker_sentiment_score": "0.06038",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049424",
                    "ticker_sentiment_score": "0.160093",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "OGN",
                    "relevance_score": "0.380012",
                    "ticker_sentiment_score": "0.282082",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.335628",
                    "ticker_sentiment_score": "0.313046",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing",
            "url": "https://www.fool.com/investing/2023/09/09/3-no-brainer-dividend-stocks-to-buy-no-matter-what/",
            "time_published": "20230909T090000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "You'll want to hold on to these players for the long term.",
            "banner_image": "https://media.ycharts.com/charts/98efea5660ead3995984ef79e2cdbe2e.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928769"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.304388,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.412861",
                    "ticker_sentiment_score": "0.400854",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.107978",
                    "ticker_sentiment_score": "0.177943",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.107978",
                    "ticker_sentiment_score": "0.177943",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities",
            "url": "https://www.prnewswire.com/news-releases/oral-antiviral-market-report-2023-demand-for-novel-therapeutics-boosts-opportunities-301921979.html",
            "time_published": "20230909T011500",
            "authors": [
                "Research and Markets"
            ],
            "summary": "DUBLIN, Sept. 8, 2023 /PRNewswire/ -- The \"Oral Antiviral Market by Indication, Drug Class, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031\" report has been added to ResearchAndMarkets.com's offering.",
            "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.158869,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.079948",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.079948",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.079948",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.079948",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.079948",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMRX",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.079948",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.079948",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "University Lab Partners announces CytoRecovery and Vena Vitals as the winners of Orange County's 2023 Pitch ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/university-lab-partners-announces-cytorecovery-and-vena-vitals-as-the-winners-of-orange-countys-2023-pitch-launch-grow-competition-301922246.html",
            "time_published": "20230908T172000",
            "authors": [],
            "summary": "University Lab Partners announces CytoRecovery and Vena Vitals as the winners of Orange County's 2023 Pitch ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.431329,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NSP",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.131803",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.07887",
                    "ticker_sentiment_score": "0.081153",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kroger Agrees To Pay $1.2 Billion In Opioid Settlements",
            "url": "https://www.forbes.com/sites/dereksaul/2023/09/08/kroger-agrees-to-pay-12-billion-in-opioid-settlements/",
            "time_published": "20230908T131322",
            "authors": [
                "Derek Saul"
            ],
            "summary": "Kroger joins fellow corporations CVS, Walgreens, Walmart and Johnson & Johnson in ponying up billions to opioid settlement funds.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64fb1d5e1989d006addcb973/0x0.jpg?format=jpg&crop=4406,2476,x363,y0,safe&width=1200",
            "source": "Forbes",
            "category_within_source": "Business",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": -0.057884,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "0.052986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "0.052986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "0.052986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "0.052986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.082899",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing",
            "url": "https://www.prnewswire.com/news-releases/perimeter-medical-imaging-ai-strengthens-leadership-team-with-appointment-of-experienced-medtech-executive-adam-hodges-as-vice-president-sales-and-marketing-301921418.html",
            "time_published": "20230908T123000",
            "authors": [
                "Perimeter Medical Imaging",
                "Inc."
            ],
            "summary": "Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2205040/Perimeter_Medical_Imaging__Inc__Perimeter_Medical_Imaging_AI_Str.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.18967,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IART",
                    "relevance_score": "0.131643",
                    "ticker_sentiment_score": "0.039487",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VAPO",
                    "relevance_score": "0.131643",
                    "ticker_sentiment_score": "0.039487",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.033107",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.131643",
                    "ticker_sentiment_score": "0.039487",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.033107",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing",
            "url": "https://www.newswire.ca/news-releases/perimeter-medical-imaging-ai-strengthens-leadership-team-with-appointment-of-experienced-medtech-executive-adam-hodges-as-vice-president-sales-and-marketing-813757976.html",
            "time_published": "20230908T123000",
            "authors": [
                "Inc.",
                "Perimeter Medical Imaging"
            ],
            "summary": "Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive ... Canada ...",
            "banner_image": "https://mma.prnewswire.com/media/2205040/Perimeter_Medical_Imaging__Inc__Perimeter_Medical_Imaging_AI_Str.jpg?p=facebook",
            "source": "Canada Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.newswire.ca",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.205518,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IART",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.038105",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VAPO",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.038105",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.033022",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.038105",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.033022",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Gains As Market Dips: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2146267/johnson-johnson-jnj-gains-as-market-dips-what-you-should-know",
            "time_published": "20230907T214520",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) closed the most recent trading day at $160.03, moving +1.28% from the previous trading session.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default242.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.972476"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.189033,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.596978",
                    "ticker_sentiment_score": "0.296113",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "U.S. Controlled Substance Market Size Worth USD 74.3 billion by 2031, Rising at a CAGR of 5.2% - Says Transparency Market Research",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34333372/u-s-controlled-substance-market-size-worth-usd-74-3-billion-by-2031-rising-at-a-cagr-of-5-2-says-t",
            "time_published": "20230907T193000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Sept. 08, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The U.S. controlled substance market is projected to flourish at a CAGR of 5.2% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 74.3 billion is anticipated for ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": -0.029315,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MJNA",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "0.203282",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "-0.015895",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "0.185271",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": " ( JNJ )  - Analyzing Johnson & Johnson's Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/short-sellers/23/09/34321492/jnj-analyzing-johnson-johnsons-short-interest",
            "time_published": "20230907T141520",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Johnson & Johnson's JNJ short percent of float has risen 232.32% since its last report. The company recently reported that it has 85.50 million shares sold short, which is 3.29% of all regular shares that are available for trading.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.265071,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.15378",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here are the 13 stocks Jim Cramer is watching, including Eli Lilly, McDonald's",
            "url": "https://www.cnbc.com/2023/09/07/here-are-the-13-stocks-jim-cramer-is-watching-including-eli-lilly-mcdonalds.html",
            "time_published": "20230907T135057",
            "authors": [
                "Jim Cramer"
            ],
            "summary": "Here are some of the tickers on my radar for Thursday, Sept. 7, taken directly from my reporter's notebook.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107284815-16916935272023-08-10t050100z_1748068659_rc2w30a1ew52_rtrmadp_0_health-usa-obesity.jpeg?v=1694094657&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.244756,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DKNG",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.240956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GIS",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "-0.433519",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.355588",
                    "ticker_sentiment_score": "0.210402",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.270773",
                    "ticker_sentiment_score": "0.166009",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.09186",
                    "ticker_sentiment_score": "-0.127127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.09186",
                    "ticker_sentiment_score": "-0.127127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLB",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.300571",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "OTIS",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.074323",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AEO",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DOCU",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.018713",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "1 Brand-New Dividend Stock Income Investors Won't Want to Miss",
            "url": "https://www.fool.com/investing/2023/09/07/1-brand-new-dividend-stock-income-investors-wont-w/",
            "time_published": "20230907T130500",
            "authors": [
                "Matthew DiLallo"
            ],
            "summary": "The recently spun-off Kenvue looks to be a high-quality dividend stock.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.947132"
                }
            ],
            "overall_sentiment_score": 0.422349,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.059935",
                    "ticker_sentiment_score": "0.083",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.591801",
                    "ticker_sentiment_score": "0.494034",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.236396",
                    "ticker_sentiment_score": "0.328144",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "J&J  ( JNJ )  to End Pulmonary Hypertension Study on Opsumit",
            "url": "https://www.zacks.com/stock/news/2145863/jj-jnj-to-end-pulmonary-hypertension-study-on-opsumit",
            "time_published": "20230907T124300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The decision to end the CTEPH study on J&J's (JNJ) Opsumit (macitentan) was made at the recommendation of the study's independent DMC, following a pre-planned interim analysis.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/cc/389.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.983605"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.143794,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CORT",
                    "relevance_score": "0.103331",
                    "ticker_sentiment_score": "0.057784",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVAX",
                    "relevance_score": "0.254573",
                    "ticker_sentiment_score": "0.11197",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EXEL",
                    "relevance_score": "0.254573",
                    "ticker_sentiment_score": "0.234481",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "-0.119654",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J to pull the plug on hypertension drug study",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-pull-plug-hypertension-drug-study-2023-09-06/",
            "time_published": "20230906T220100",
            "authors": [
                "Reuters"
            ],
            "summary": "The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange ( NYSE ) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid/File photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/SNQW2DNWQJL7HKY6HPW6IPNLNA.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": -0.033565,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.451494",
                    "ticker_sentiment_score": "0.175947",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34289484/johnson-johnson-cancer-drug-rybrevant-shows-improvement-in-broader-lung-cancer-population",
            "time_published": "20230906T181141",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Janssen, a unit of Johnson & Johnson JNJ, released topline results from the three-arm Phase 3 MARIPOSA-2 study evaluating Rybrevant ( amivantamab-vmjw ) regime versus chemotherapy alone, targeting epidermal growth factor receptor ( EGFR ) and mesenchymal-epithelial transition ( MET ) .",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/06/jnj.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.101384,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.350564",
                    "ticker_sentiment_score": "0.147165",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.157912",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stocks on the Mend: A Mean Reversion Duo",
            "url": "https://www.zacks.com/commentary/2145594/stocks-on-the-mend-a-mean-reversion-duo",
            "time_published": "20230906T171600",
            "authors": [
                "Andrew Rocco"
            ],
            "summary": "September is starting in classic, historically weak form. However, if the market finds it's footing, two stocks have explosive, reversion to the mean potential.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/8a/2449.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.197817,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AMD",
                    "relevance_score": "0.708432",
                    "ticker_sentiment_score": "0.522995",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.274834",
                    "ticker_sentiment_score": "0.218445",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVAX",
                    "relevance_score": "0.360752",
                    "ticker_sentiment_score": "0.099524",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.185306",
                    "ticker_sentiment_score": "0.054842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.185306",
                    "ticker_sentiment_score": "0.054842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.185306",
                    "ticker_sentiment_score": "0.054842",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today? - Cidara Therapeutics  ( NASDAQ:CDTX ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34281425/why-is-infectious-diseases-focused-cidara-therapeutics-stock-trading-higher-today",
            "time_published": "20230906T152631",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Cidara Therapeutics Inc CDTX shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson JNJ, decided to proceed with CD388 ( JNJ-0953 ) , which is being developed for the universal prevention of influenza A and B.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/06/cdtx.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.123822,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CDTX",
                    "relevance_score": "0.399204",
                    "ticker_sentiment_score": "0.076464",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.514619",
                    "ticker_sentiment_score": "-0.022414",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J says drug combo contains lung cancer from spreading for longer duration",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-says-drug-combo-contains-lung-cancer-spreading-longer-duration-2023-09-06/",
            "time_published": "20230906T131400",
            "authors": [
                "Reuters"
            ],
            "summary": "The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange ( NYSE ) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/QEI6OATDYJNOBATSAMAVCP57MI.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.054707,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.388879",
                    "ticker_sentiment_score": "-0.100101",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Jim Cramer's top 10 things to watch in the stock market Wednesday",
            "url": "https://www.cnbc.com/2023/09/06/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday-.html",
            "time_published": "20230906T130822",
            "authors": [
                "Jim Cramer"
            ],
            "summary": "Equities are lower in premarket trading Wednesday, while Arm Holdings' roadshow ahead of a planned initial public offering is impressive.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107290745-1692802098753-gettyimages-1619153799-ARM_IPO.jpeg?v=1694005702&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997405"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.076538,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TJX",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.161328",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "D",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.112032",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TTD",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.024715",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SFTBF",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.078215",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STZ",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.17828",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CHTR",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "-0.3583",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.028359",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "South Africa 'held to ransom' by big pharma, overcharged for COVID vaccines",
            "url": "https://www.aljazeera.com/news/2023/9/6/south-africa-held-to-ransom-by-big-pharma-overcharged-for-covid-vaccines",
            "time_published": "20230906T122710",
            "authors": [
                "Sumayya Ismail"
            ],
            "summary": "Johannesburg, South Africa - Big pharmaceutical companies \"bullied\" South Africa into signing unfair agreements that forced the country to overpay for COVID-19 vaccines compared with Western nations, according to a nonprofit that lobbied for the details to be released.",
            "banner_image": "https://www.aljazeera.com/wp-content/uploads/2023/09/INTERACTIVE-South-Africa-Covid-Vaccines-1693996006.png?w=770&resize=770%2C770",
            "source": "Al Jareeza",
            "category_within_source": "n/a",
            "source_domain": "www.aljazeera.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.175778,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.045202",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.239305",
                    "ticker_sentiment_score": "-0.21999",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "-0.130014",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "-0.130014",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "More Than A Third Of S&P 500 Stocks Get Kicked Out In Nine Years",
            "url": "https://www.investors.com/etfs-and-funds/sectors/sp-500-stocks-more-than-a-third-get-kicked-out-in-nine-years/",
            "time_published": "20230906T120000",
            "authors": [
                "MATT KRANTZ",
                "Investor's Business Daily"
            ],
            "summary": "Think you know the world's most-popular index: The S&P 500? It's very different from what it was just nine years ago - and more changes are coming. Nearly 180 stocks in the S&P 500, or roughly a third of the index, have been replaced since 2015, says data from S&P Dow Jones Indices.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/09/Stock-kickoutdoor-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.095117,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LNC",
                    "relevance_score": "0.330654",
                    "ticker_sentiment_score": "0.021207",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NWL",
                    "relevance_score": "0.330654",
                    "ticker_sentiment_score": "0.021207",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BG",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "0.050492",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.251247",
                    "ticker_sentiment_score": "0.068968",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "0.050492",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "0.050492",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PODD",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "0.050492",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABNB",
                    "relevance_score": "0.251247",
                    "ticker_sentiment_score": "0.068968",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PANW",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "0.050492",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cidara Therapeutics Announces Janssen's Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza - Cidara Therapeutics  ( NASDAQ:CDTX ) ",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34273802/cidara-therapeutics-announces-janssens-election-to-proceed-under-its-license-agreement-relating-to",
            "time_published": "20230906T120000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Decision follows promising interim efficacy and safety data from ongoing Phase 1 and 2a trials Cidara to receive a $7 million milestone payment and is eligible to receive an additional $685 million in milestones, plus royalties SAN DIEGO, Sept. 06, 2023 ( GLOBE NEWSWIRE ) -- Cidara Therapeutics, ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.188125,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CDTX",
                    "relevance_score": "0.24847",
                    "ticker_sentiment_score": "0.201016",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.059176",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is J&J a Buy After the Kenvue Separation?",
            "url": "https://www.fool.com/investing/2023/09/06/is-jj-a-buy-after-the-kenvue-separation/",
            "time_published": "20230906T100000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "J&J shares have been on the decline.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.990678"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.275003,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.393241",
                    "ticker_sentiment_score": "0.329467",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "0.121146",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Idorsia reacquires the world-wide rights to aprocitentan",
            "url": "https://www.globenewswire.com/news-release/2023/09/06/2737993/0/en/Idorsia-reacquires-the-world-wide-rights-to-aprocitentan.html",
            "time_published": "20230906T050000",
            "authors": [
                "Idorsia Pharmaceuticals Ltd"
            ],
            "summary": "Ad hoc announcement pursuant to Art. 53 LR ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/bb724119-468d-4b1d-8206-3c2175d07f2b",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.094999,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "IDRSF",
                    "relevance_score": "0.344364",
                    "ticker_sentiment_score": "0.328869",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.016172",
                    "ticker_sentiment_score": "0.098222",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34252783/check-out-what-whales-are-doing-with-jnj",
            "time_published": "20230905T201552",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.10852,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MS",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.817578",
                    "ticker_sentiment_score": "0.288945",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's Why You Should Retain Boston Scientific  ( BSX )  Now",
            "url": "https://www.zacks.com/stock/news/2145006/heres-why-you-should-retain-boston-scientific-bsx-now",
            "time_published": "20230905T155900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Investors are optimistic about Boston Scientific (BSX) on growth in the legacy business and upbeat guidance.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.998917"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.316063,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "EW",
                    "relevance_score": "0.051111",
                    "ticker_sentiment_score": "0.077486",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.051111",
                    "ticker_sentiment_score": "0.077486",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.051111",
                    "ticker_sentiment_score": "0.077486",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.25142",
                    "ticker_sentiment_score": "0.326973",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.051111",
                    "ticker_sentiment_score": "0.077486",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.051111",
                    "ticker_sentiment_score": "0.077486",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HAE",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.113814",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QTRX",
                    "relevance_score": "0.102013",
                    "ticker_sentiment_score": "0.083271",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top Stories Tuesday, Sep 5: Facebook News To Shut Down in Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale - Air France  ( OTC:AFLYY ) , AstraZeneca  ( NASDAQ:AZN ) ",
            "url": "https://www.benzinga.com/news/23/09/34237785/facebook-news-to-shut-down-in-europe-warner-bros-discovery-revises-outlook-as-strike-bites-mancheste",
            "time_published": "20230905T141930",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Meta Platforms Inc META announced a significant development regarding Facebook News in the U.K., France, and Germany. The dedicated news tab on Facebook, known as Facebook News, will cease to exist in early December.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/05/facevook_-tlzhfrlj6ny-unsplash_0.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.972756"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.154688,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.01556",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.316337",
                    "ticker_sentiment_score": "0.238782",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "-0.036101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.125995",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AFRAF",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.044418",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.16144",
                    "ticker_sentiment_score": "0.079532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MBGAF",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.178293",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.121445",
                    "ticker_sentiment_score": "0.248203",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EADSF",
                    "relevance_score": "0.121445",
                    "ticker_sentiment_score": "0.065832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RNSDF",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.046773",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.092675",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.16144",
                    "ticker_sentiment_score": "0.226054",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.121445",
                    "ticker_sentiment_score": "0.104666",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.185919",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.153068",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MANU",
                    "relevance_score": "0.121445",
                    "ticker_sentiment_score": "-0.02249",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34235802/johnson-johnsons-growth-strategy-post-tylenol-parent-kenvue-split-paving-the-way-for-medical-inno",
            "time_published": "20230905T133911",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Johnson & Johnson JNJ is gearing up to use the proceeds from the recent separation of its consumer-health segment Kenvue Inc KVUE to bolster its growth in pharmaceuticals and medical technology. This growth strategy could encompass new acquisitions, enhancement of product offerings, and a deeper ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/05/tylenol.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.263847,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.651499",
                    "ticker_sentiment_score": "0.454866",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.426225",
                    "ticker_sentiment_score": "0.395761",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Arm Plans To Go Public At Up To $55 Billion Valuation-Biggest IPO Since Rivian's In 2021",
            "url": "https://www.forbes.com/sites/dereksaul/2023/09/05/arm-plans-to-go-public-at-up-to-55-billion-valuation-biggest-ipo-since-rivians-in-2021/",
            "time_published": "20230905T133850",
            "authors": [
                "Derek Saul"
            ],
            "summary": "The valuation comes in far below the reported $64 billion internal valuation for the SoftBank-owned chip designer.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64f72ecda4675ed610b0157e/0x0.jpg?format=jpg&crop=4547,2559,x0,y0,safe&width=1200",
            "source": "Forbes",
            "category_within_source": "Markets",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.9545"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.175758,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "0.126603",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "0.062677",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "0.062677",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "0.126603",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SFTBF",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "0.126603",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "0.126603",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RIVN",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "-0.025013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "0.062677",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership - AstraZeneca  ( NASDAQ:AZN ) , Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34228654/legal-twist-in-drug-price-negotiation-federal-judge-quits-case-amid-allegations-of-stock-ownershi",
            "time_published": "20230905T123832",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "On Friday, Judge Thomas Rose, serving in the U.S. District Court for the Southern District of Ohio, opted to step down from the case on the same day the Revolving Door Project, a nonprofit organization, revealed his ownership of stocks in Johnson & Johnson JNJ and AstraZeneca Plc AZN.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/05/pharma-photo_by_pina_messina_on_unsplash.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.085977,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "0.194566",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.449503",
                    "ticker_sentiment_score": "0.14674",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.234684",
                    "ticker_sentiment_score": "-0.025921",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.345674",
                    "ticker_sentiment_score": "-0.017137",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors - Eterna Therapeutics  ( NASDAQ:ERNA ) ",
            "url": "https://www.benzinga.com/pressreleases/23/09/g34233101/eterna-therapeutics-appoints-biopharma-industry-veteran-dorothy-clarke-to-board-of-directors",
            "time_published": "20230905T123049",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "CAMBRIDGE, Mass., Sept. 05, 2023 ( GLOBE NEWSWIRE ) -- Eterna Therapeutics Inc. ERNA ( \"Eterna\" or the \"Company\" ) , a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the appointment of ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.210798,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ERNA",
                    "relevance_score": "0.253866",
                    "ticker_sentiment_score": "0.087757",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.253866",
                    "ticker_sentiment_score": "0.050322",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors",
            "url": "https://www.globenewswire.com/news-release/2023/09/05/2737383/0/en/Eterna-Therapeutics-Appoints-Biopharma-Industry-Veteran-Dorothy-Clarke-to-Board-of-Directors.html",
            "time_published": "20230905T123000",
            "authors": [
                "Eterna Therapeutics"
            ],
            "summary": "CAMBRIDGE, Mass., Sept. 05, 2023 ( GLOBE NEWSWIRE ) -- Eterna Therapeutics Inc. ( Nasdaq: ERNA ) ( \"Eterna\" or the \"Company\" ) , a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/4072f2f1-de68-4422-9cb2-2423b7e665da",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.576289"
                }
            ],
            "overall_sentiment_score": 0.226702,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ERNA",
                    "relevance_score": "0.048523",
                    "ticker_sentiment_score": "0.051354",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.144853",
                    "ticker_sentiment_score": "0.03332",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024",
            "url": "https://www.globenewswire.com/news-release/2023/09/05/2736936/0/en/Addex-ADX71149-Phase-2-Epilepsy-Study-Expected-to-Readout-Data-in-Q2-2024.html",
            "time_published": "20230905T050000",
            "authors": [
                "Addex Therapeutics"
            ],
            "summary": "Ad Hoc Announcement Pursuant to Art. 53 LR ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/e6c12443-4244-46f9-909c-5ab241bbea41",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.182072,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IZQVF",
                    "relevance_score": "0.0362",
                    "ticker_sentiment_score": "0.047834",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADXN",
                    "relevance_score": "0.28346",
                    "ticker_sentiment_score": "0.088348",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.072326",
                    "ticker_sentiment_score": "0.086543",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ: 3 Pharma Stocks to Consider Prescribing to for Quality",
            "url": "https://stocknews.com/news/jnj-azn-rdy-3-pharma-stocks-to-consider-prescribing-to-for-quality/",
            "time_published": "20230904T161832",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "The pharmaceutical industry is expected to grow significantly as a result of global medical demands, aging population, technological advancements, and government investments in healthcare infrastructure, which will drive demand for pharmaceutical products and services.",
            "banner_image": "https://stocknews.com/wp-content/uploads/2021/03/shutterstock_745024336-scaled.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999612"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.752319"
                }
            ],
            "overall_sentiment_score": 0.244843,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.139467",
                    "ticker_sentiment_score": "0.150346",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.274705",
                    "ticker_sentiment_score": "0.11876",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights",
            "url": "https://www.prnewswire.com/news-releases/decoding-the-global-vasectomy-market-2023-trends-strategies-and-regulatory-insights-301916835.html",
            "time_published": "20230904T160000",
            "authors": [
                "Research and Markets"
            ],
            "summary": "DUBLIN, Sept. 4, 2023 /PRNewswire/ -- The \"Global Vasectomy Market ( 2023-2028 ) by Drug, Type, Patients, End Users, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis\" report has been added to ResearchAndMarkets.com's offering.",
            "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.311721,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABT",
                    "relevance_score": "0.088147",
                    "ticker_sentiment_score": "0.211476",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.088147",
                    "ticker_sentiment_score": "0.211476",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.088147",
                    "ticker_sentiment_score": "0.211476",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.088147",
                    "ticker_sentiment_score": "0.211476",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Binge-eating Disorder Treatment Market size is set to grow by USD 578.04 million from 2022 to 2027 | The increasing ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/binge-eating-disorder-treatment-market-size-is-set-to-grow-by-usd-578-04-million-from-2022-to-2027--the-increasing-prevalence-of-binge-eating-disorder-drives-the-market---technavio-301916031.html",
            "time_published": "20230904T151500",
            "authors": [],
            "summary": "Binge-eating Disorder Treatment Market size is set to grow by USD 578.04 million from 2022 to 2027 | The increasing ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.161259,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DNPUF",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "0.057979",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TNXP",
                    "relevance_score": "0.092036",
                    "ticker_sentiment_score": "0.108341",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSUMF",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "0.057979",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "0.057979",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "0.057979",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMER",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "0.057979",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAK",
                    "relevance_score": "0.046095",
                    "ticker_sentiment_score": "0.057979",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Absorbable Sutures Market size to grow by USD 622.72 million from 2022 to 2027 | The number of surgical procedures ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/absorbable-sutures-market-size-to-grow-by-usd-622-72-million-from-2022-to-2027--the-number-of-surgical-procedures-globally-drives-market-growth---technavio-301916016.html",
            "time_published": "20230904T110000",
            "authors": [],
            "summary": "Absorbable Sutures Market size to grow by USD 622.72 million from 2022 to 2027 | The number of surgical procedures ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.174892,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.05387",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.05387",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05387",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFX",
                    "relevance_score": "0.05387",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J's $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion ﻿",
            "url": "https://www.wsj.com/articles/j-js-40-billion-split-off-sets-stage-for-pharma-medical-tech-expansion-817701c1",
            "time_published": "20230904T093000",
            "authors": [
                "Mark Maurer"
            ],
            "summary": "The healthcare giant's separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses.",
            "banner_image": "https://images.wsj.net/im-846213?width=700&height=495",
            "source": "Wall Street Journal",
            "category_within_source": "Business",
            "source_domain": "www.wsj.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.114838,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.546745",
                    "ticker_sentiment_score": "0.213927",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032",
            "url": "https://www.fool.com/investing/2023/09/03/4-buffett-stocks-that-could-join-the-trillion/",
            "time_published": "20230903T134500",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "These companies all offer goods or services most of us use regularly.",
            "banner_image": "https://media.ycharts.com/charts/af6ba5b26bde34be0adf79c6fd9eb91c.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.311203,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MA",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.325296",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.40711",
                    "ticker_sentiment_score": "0.374879",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.278486",
                    "ticker_sentiment_score": "0.29055",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.278486",
                    "ticker_sentiment_score": "0.328313",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is It Too Late to Buy Veeva Systems Stock?",
            "url": "https://www.fool.com/investing/2023/09/03/is-it-too-late-to-buy-veeva-systems-stock/",
            "time_published": "20230903T114000",
            "authors": [
                "Leo Sun"
            ],
            "summary": "This niche cloud software company's growth is accelerating again.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F746256%2Fscientists-tablet-computer.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999998"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.187387,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "VEEV",
                    "relevance_score": "0.134214",
                    "ticker_sentiment_score": "0.08119",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DTST",
                    "relevance_score": "0.067347",
                    "ticker_sentiment_score": "0.089204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.067347",
                    "ticker_sentiment_score": "0.089204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.067347",
                    "ticker_sentiment_score": "0.089204",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Sen. Tommy Tuberville is worth at least $4.5 million, according to his financial disclosures",
            "url": "https://www.businessinsider.com/tommy-tuberville-net-worth-financial-disclosures-2023-8",
            "time_published": "20230902T150000",
            "authors": [
                "Madison Hall"
            ],
            "summary": "Tommy Tuberville net worth is at least $4.5 million: disclosures - Business Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.081762,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "X",
                    "relevance_score": "0.056275",
                    "ticker_sentiment_score": "0.093906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.056275",
                    "ticker_sentiment_score": "0.002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.056275",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056275",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?",
            "url": "https://www.fool.com/investing/2023/09/02/is-this-incredible-dividend-stock-still-a-buy-foll/",
            "time_published": "20230902T113000",
            "authors": [
                "Matthew DiLallo"
            ],
            "summary": "Johnson & Johnson has completed its separation of Kenvue.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F746035%2Fjnj-pro-forma.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.307823,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.455525",
                    "ticker_sentiment_score": "0.417271",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.455525",
                    "ticker_sentiment_score": "0.401015",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "8 Pharma Stocks Affected by New Drug Price Negotiation Rules",
            "url": "https://www.fool.com/investing/2023/09/02/8-pharma-stocks-affected-by-new-drug-price-negotia/",
            "time_published": "20230902T105100",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F745972%2Fbrilliant-scientist-with-tablet-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.990893"
                }
            ],
            "overall_sentiment_score": 0.066437,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.094762",
                    "ticker_sentiment_score": "-0.093469",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.094762",
                    "ticker_sentiment_score": "0.126491",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.109774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.187207",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.040275",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Bone Replacement Market to grow by USD 5.611 billion from 2022 to 2027 | North America to contribute 38% of the ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/bone-replacement-market-to-grow-by-usd-5-611-billion-from-2022-to-2027--north-america-to-contribute-38-of-the-market-growth---technavio-301915487.html",
            "time_published": "20230902T010000",
            "authors": [],
            "summary": "Bone Replacement Market to grow by USD 5.611 billion from 2022 to 2027 | North America to contribute 38% of the ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.233717,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.090474",
                    "ticker_sentiment_score": "0.12463",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMED",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CFMS",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NUVA",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KYOCF",
                    "relevance_score": "0.04531",
                    "ticker_sentiment_score": "0.065755",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2143952/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know",
            "time_published": "20230901T214515",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "In the latest trading session, Johnson & Johnson (JNJ) closed at $160.48, marking a -0.74% move from the previous day.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default24.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.169436,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.608634",
                    "ticker_sentiment_score": "0.353132",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Prison healthcare giant Corizon reaches tentative bankruptcy deal that could shortchange prisoners; Sen. Elizabeth Warren pledges oversight",
            "url": "https://www.businessinsider.com/corizon-health-bankruptcy-could-lowball-malpractice-claims-2023-8",
            "time_published": "20230901T165100",
            "authors": [
                "Nicole Einbinder",
                "Dakin Campbell"
            ],
            "summary": "Corizon reaches bankruptcy deal that may allow it to \"profit at the expense of creditors\" - Business Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.146932,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.031405",
                    "ticker_sentiment_score": "-0.193802",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.031405",
                    "ticker_sentiment_score": "-0.293594",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Orthopedic implants market to grow by USD 14.0616 billion from 2022 to 2027 | The increasing incidence of knee ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/orthopedic-implants-market-to-grow-by-usd-14-0616-billion-from-2022-to-2027--the-increasing-incidence-of-knee-injuries-to-boost-market-growth---technavio-301915326.html",
            "time_published": "20230901T151500",
            "authors": [],
            "summary": "Orthopedic implants market to grow by USD 14.0616 billion from 2022 to 2027 | The increasing incidence of knee ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.123335,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ENOV",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OFIX",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMED",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNMD",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KIDS",
                    "relevance_score": "0.044141",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Amgen's $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement",
            "url": "https://www.forbes.com/sites/tylerroush/2023/09/01/amgens-278-billion-purchase-of-horizon-therapeutics-on-after-ftc-settlement/",
            "time_published": "20230901T145309",
            "authors": [
                "Ty Roush"
            ],
            "summary": "The agency previously argued the merger could harm patients who are prescribed Horizon's two fastest-growing drugs.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64f1fa63063fd220ce1e813e/0x0.jpg?format=jpg&crop=2203,1238,x0,y119,safe&width=1200",
            "source": "Forbes",
            "category_within_source": "Business",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.045387,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.103331",
                    "ticker_sentiment_score": "-0.164441",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "HZNP",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "-0.194922",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.103331",
                    "ticker_sentiment_score": "-0.078932",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.103331",
                    "ticker_sentiment_score": "-0.078932",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Former Best Buy CEO Hubert Joly On How To 'Refound' A Company",
            "url": "https://www.forbes.com/sites/petercohan/2023/09/01/former-best-buy-ceo-hubert-joly-on-how-to-refound-a-company/",
            "time_published": "20230901T132223",
            "authors": [
                "Peter Cohan"
            ],
            "summary": "Invest in companies whose leaders are curious, have intellectual humility, create meaning for workers, and capture short- and long-term growth opportunities ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64f074cae6080cc5621e813e/0x0.jpg?format=jpg&width=1200",
            "source": "Forbes",
            "category_within_source": "Money",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.994953"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.232163,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BBY",
                    "relevance_score": "0.524949",
                    "ticker_sentiment_score": "0.368254",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.021106",
                    "ticker_sentiment_score": "0.133164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.021106",
                    "ticker_sentiment_score": "0.087758",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nvidia's market cap climbs amid tech turbulence in August",
            "url": "https://www.reuters.com/business/global-markets-marketcap-2023-09-01/",
            "time_published": "20230901T120309",
            "authors": [
                "Reuters"
            ],
            "summary": "A smartphone with a displayed NVIDIA logo is placed on a computer motherboard in this illustration taken March 6, 2023. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",
            "banner_image": "https://graphics.reuters.com/GLOBAL-MARKETS/akpeazweepr/chart.png",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.176898,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "-0.036585",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "-0.036585",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.244109",
                    "ticker_sentiment_score": "0.150325",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TCTZF",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "-0.018092",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "-0.035067",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "What's Happening With Johnson & Johnson Stock?",
            "url": "https://www.forbes.com/sites/greatspeculations/2023/09/01/whats-happening-with-johnson--johnson-stock/",
            "time_published": "20230901T120046",
            "authors": [
                "Trefis Team"
            ],
            "summary": "Johnson & Johnson stock (NYSE: JNJ) has seen a 3% fall in a month, compared to a 2% fall for the broader S&P500 index.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64f171c3c826a8a8881e8142/0x0.jpg?format=jpg&width=1200",
            "source": "Forbes",
            "category_within_source": "Money",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.061589,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.045189",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.672533",
                    "ticker_sentiment_score": "0.133516",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should Franklin U.S. Low Volatility High Dividend Index ETF  ( LVHD )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2143387/should-franklin-us-low-volatility-high-dividend-index-etf-lvhd-be-on-your-investing-radar",
            "time_published": "20230901T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default215.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.150685,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.118354",
                    "ticker_sentiment_score": "0.067379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.118354",
                    "ticker_sentiment_score": "0.067379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.118354",
                    "ticker_sentiment_score": "0.067379",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Artificial Bone Marrow Market to grow by USD 170.77 million from 2022 to 2027 | The increasing prevalence of bone ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/artificial-bone-marrow-market-to-grow-by-usd-170-77-million-from-2022-to-2027--the-increasing-prevalence-of-bone-disorders-and-injuries-drives-the-market---technavio-301915130.html",
            "time_published": "20230901T083000",
            "authors": [],
            "summary": "Artificial Bone Marrow Market to grow by USD 170.77 million from 2022 to 2027 | The increasing prevalence of bone ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.246047,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OFIX",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NUVA",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HOCPF",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.040969",
                    "ticker_sentiment_score": "0.016619",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        }
    ]
}